An in-vitro investigation to determine the neuroinflammatory response of CNS cells to oral bacteria and their virulence factors. by Previn, Rahul
i 
 
 
 
An in-vitro investigation to determine the neuroinflammatory response of 
CNS cells to oral bacteria and their virulence factors 
 
 
 
 
 
 
by 
 
Rahul Previn 
 
 
 
 
 
 
 
 
A thesis submitted in partial fulfilment for the requirements for the degree of 
MSc (by Research) at the University of Central Lancashire 
 
February 2013 
ii 
 
ACKNOWLEDGEMENTS  
 
I would like to thank the University of Central Lancashire, UK for the opportunity to 
undertake my postgraduate research degree. I wish to thank my Principle Investigator (PI) 
and Director of studies (D0S), Dean, Prof St John Crean for steering me into an interesting, 
and a hybrid dental-neurosciences project. His inspirational and expert guidance made the 
challenges of education seem more manageable. I would also like to thank Dr Peter 
Robinson, my Research Degrees Tutor (RDT), as without his expert help in getting through 
the various postgraduate degree hurdles would have been impossible. I would like to express 
my sincere gratitude to my supervisor, Dr Sim Singhrao for the daily guidance, advice, and 
patience throughout the practical work of the project. I would also like to thank Miss Sophie 
Poole, currently a PhD student, for ad-hoc assistance in the lab and for guidance in 
interpreting row data whenever she was nearby. I would like to acknowledge Prof. M. Curtis 
for the essential reagents I used to investigate my research question without which, my 
project would be incomplete. Above all, I would like to express my heartfelt gratitude to my 
family, especially my mother for her undying love, invaluable moral and financial support 
and encouragement to do well, during my time away from home. Finally I wish to say a huge 
thank you to all my friends and unmentioned staff members at UCLan for their understanding 
and providing speedy help when ever needed.   
 
 
 
 
 
 
 
 
 
 
 
 
iii 
 
 
 
 
 
 
 
 
 
 
Student Declaration 
 
 
 
 
*I declare that no material contained in the thesis has been used in any other submission for 
an academic award and is solely my own work 
 
 
 
 
 
 
 
 
Signature of Candidate 
 
 
 
 ............................................................................................................ 
 
 
Type of Award  
 
 
MSc (by Research) 
............................................................................................................... 
 
 
School          
 
Postgraduate Medical and Dental Education 
 ................................................................................................................      
 
 
iv 
 
Table of Contents                                                                              Page 
List of figures           vi 
List of Table                           viii 
List of abbreviation                                                                               ix 
Abstract           1 
Chapter 1: General Introduction        4 
1.1 Origins of the concept for research      4 
1.1.1 Experimental advances in favour of the Miller and Hunter concept 5 
1.1.2 Periodontal disease         6
 1.1.2.1 Porphyromonasgingivalis      8 
1.1.2.2 Virulence factors of P. gingivalis     9 
 
1.2 Aging, structure and function of the Central Nervous System and 
neuroinflammation         12 
 1.2.1 General Introduction        12 
            1.2.1.1 The Brain        13 
 
 1.2.2 Cellular neurobiology       16 
 1.2.2.1 The nerve cell function and structure    16 
                  1.2.2.2 Extrinsic factors contributing to neuroinflammation  25
  
  
1.3 The Rationale         27 
 1.3.1 Aim          27 
  1.3.1.1 Objectives        27 
  1.3.1.2 Research approach       27 
Chapter 2: Investigating responses of CNS cells to P. gingivalis virulence 
factors                                                                                                               29 
2.1 Introduction (in brief)         29 
2.1.1 Materials and Methods        29 
 2.1.1.1 List and source of reagents     29 
 2.1.1.2 In vitro culture       30 
v 
 
 2.1.1.3 Immunofluorescence labelling     34 
 2.1.1.4 Biochemistry       36 
 2.1.1.5 Casting gels and SDS-PAGE     38 
 
2.2 Results 41 
 2.2.1 SVGp12 a model cell line        41 
  2.2.1.1 Immunofluorescence                          42 
 2.2.2 IMR32 a model cell line        54 
2.2.2.1 Immunofluorescence                          55  
         
Chapter 3: General Discussion         62 
             3.1 Exposure of cells to P.gingivalis virulence factors affect cellular immune 
 responses          63 
             3.2 Repeat-exposure of cells to P.gingivalis virulence factors did not contribute to 
exaggerated pro-inflammatory cytokine release       69 
             3.3 Exposure of cells to P.gingivalis virulence factors the actin cytoskeleton but, 
without cell death                                                                                                                    69 
Chapter 4: References Section        73 
 
  
vi 
 
                                    List of figure 
 
 
Figure                                                   Title Page 
   
1.1. Chronic periodontal disease  7 
1.2.a. Subgingival pocket with bacteria  7 
1.2.b. End stage chronic periodontitis  7 
1.3 Ultrastructure of P. gingivalis 9 
1.4 High resolution image of the outer membrane vesicles  10 
1.5 
 
 
1.6a 
Schematic presentation of a human brain hemisphere  
 
An overview of major limbic system structures in the brain form 
13 
 
 
15 
1.6b Anatomical regions associated with the hippocampus 15 
1.7 Hippocampus :the brain region responsible for memory                          16 
1.8 A peripheral nerve and its anatomical features 17 
1.9 Electron micrograph showing a synapse with synaptic vesicles 18 
1.10 The intact blood brain barrier 21 
1.11 Reactive astrocytes in a disease condition 22 
1.12 Activated microglial cells in a disease condition 23 
1.13 Pathway for the recognition of bacterial lipopolysaccharide 26 
2.1 Phase contrast microscopy 41 
2.2 The effect of antibiotics (pen/Strep) on SVGp12 cell lines in culture 42 
2.3 SVGp12 cell line has astrocyte orgin 43 
2.4 SVGp12 cell line expresses the surface membrane receptor, LPS  44 
2.5 Intracellular localisation of gingipains in SVGp12 cell line following endotoxin 
challenge  
44 
2.6 Specific response of SVGp12 cells to endotoxins (LPS) 45 
2.7 Morphological responses of SVGp12 cells to endotoxins  45 
2.8 CD14 receptor decreases following challenge with endotoxins (LPS)  46 
2.9 Monitoring proliferation following endotoxin repeat-exposures on SVGp12 cells 47 
2.10 Change in GFAP protein on SVGp12 cells in between endotoxin challenges 47 
2.11 Effects on CD14 receptor on SVGp12 cell surface membrane in between 
exposures to endotoxins 
48 
vii 
 
2.12 SVGp12 cells absorb LPS 
 
49 
2.13 SVGp12 cells internalise gingipains 50 
2.14 
 
 
2.15 
SVGp12 cells loss GFAP protein following an endotoxin (LPS) challenge  
 
Standard curve for the TNF-α instant ELISA  
51 
 
 
52 
2.16 Phase contrast microscopy 54 
2.17 Neuronal origins of the IMR32 cell line and detection of the LPS receptor 55 
2.18 IMR32 cell line expresses actin  55 
2.19 Gingipains is not internalised by IMR32 cell line  56 
2.20 Morphological responses of IMR32 cells to endotoxins (LPS) 56 
2.21 IMR32 cells lose CD14 receptor protein following an endotoxin challenge 57 
2.22 Phase contrast microscopy for primary cell culture 59 
2.23 To determine if astrocytes are part of the mixed primary cells 59 
2.24 Mixed primary cells express the LPS receptor  60 
2.25 The response of primary cells to endotoxins (LPS) 60 
3.1 Schematic diagram representing interaction of LPS to CD14 signalling pathways 66 
 
 
 
 
 
 
 
 
 
viii 
 
                                                                  List of Tables  
Figure                                                          Title Page 
2.1. Stock reagents and volumes to cast gels  38 
2.2 The antibodies and their dilutions used for immunoblotting 40 
2.3 Concentration of released TNF-α  52 
2.4 The Bioplex bead array ELISA (24h interval) 53 
2.5 The Bioplex bead array ELISA following repeat exposure to endotoxin 54 
2.6 
 
Data from the eBioscience instant ELISA assay for TNF-α cytokine (24h 
interval)  
58 
2.7 The  Bioplex bead array ELISA for IMR32 (24h interval) 58 
 
 
 
 
 
 
 
 
 
 
  
ix 
 
LIST OF ABBREVIATIONS AND SYMBOLS  
 
α Methylene the first methylene after the hydroxyl in an acyl chain  
β Methylene the second methylene after the hydroxyl in an acyl chain  
μg/ml Microgram (10-6grams) per milliliter 
µl  Microliter 
µg Micrograms 
µm Micrometers 
ºC                   Degrees Celsius; unit of temperature  
AD                 Alzheimer’s disease 
AMPA   Alpha-amino-3-hydroxyl-5-methyl-4-isoxazole-propionate 
APS  Ammoniumpersulphate 
ATCC           American Type Culture Collection 
BBB Blood brain barrier 
BrdU Bromodeoxyunidine 
BSA Bovine serum albumin 
CA.1-4 Cornisammonis regions 1-4 
CD14             Cluster of differentiation 14 protein 
CD4
+
 Cluster of differentiation 4 
cm
3 
Cubic centimetre 
cm
2
  Square centimetre  
CNS               Central nervous system 
CO2  Carbon dioxide  
CR1  Complement receptors 1 
CR3  Complement receptors 3 
CR4  Complement receptors 4 
CSF   Cerebrospinal fluid 
dH20 Distilled water 
DMEM           Dulbecco’s modified essential medium  
DMSO            Dimethyl sulphoxide 
DNA  Deoxyribonucleicacid 
DNAse I Deoxyribonuclease I  
ECL  Enhanced chemiluminescence 
EDTA Ethylenediaminetetraaceticacid 
ELISA Enzyme-linked immunosorbent assay 
EMEM  Eagle’s minimal essential medium 
ERK  Extracellular-signal-regulated kinases 
FBS Foetal bovine serum 
FCS  Foetal calf serum 
FITC  Fluorescein isothiocyanate 
FISH Fluorescence in-situ hybridisation 
g Gram 
GABA Gamma-aminobutyric acid 
GFAP   Glial fibrillary acidic protein 
GM-CSF         Granulocyte macrophage colony-stimulating factor 
GPI                Glycosylphosphatidylinositol 
h Hour 
HCl  Hydrogen chloride 
HRP Horse radish peroxidase 
IFN-β              Interferon-β 
x 
 
IFN-γ  Interferon-gamma 
IgG ImmunoglobulinG 
IL-1                 Interleukin-1  
IL-1β  Interleukin-1 beta 
IL-2                 Interleukin-2  
IL-4                 Interleukin-4  
IL-6                 Interleukin-6  
IL-8                 Interleukin-8  
IL-10               Interleukin-10  
IL-13               Interleukin-13 
IMR32 Human neuroblastoma cell lines 
IU International units 
KCl Potassium chloride 
kDa Kilodalton (10
3
Daltons); unit of mass 
KH2PO4  Potassium dihydrogen phosphate 
L                   Liter 
LPS              Lipopolysaccharide  
LTP  Long term potentiation 
M                 Molar 
mA Milli amps 
MAPK         Mitogen-activated protein kinase  
MD-2           Myeloid differentiation protein 2 
MHC Major histocompatibility complex 
MyD88        Myeloid differentiation primary response gene 88 
mg/ml Milligrams (10
-3
 grams) per milliliter 
ml  Millilitre 
mM Millimolar (10
-3
moles per liter): unit of concentration 
MgCl2 Magnesium chloride 
N Number 
nAChR  Nicotinicacetylcholine receptor 
NaCl  Sodium chloride 
NEAA  Non-essential amino acids 
NF-κB Nuclear factor- kappa B  
nm Nano meter 
NMDA  n-methyl-D-aspartate 
NO  Nitric oxide 
NP40 Nonidet P-40 (octyl phenoxypolyethoxylethanol) 
p38 MAPK        Mitogen-activated protein kinase 38 
PAMP        Pathogen-associated molecular pattern  
PBS            Phosphate buffered saline 
PGE2  Prostaglandin E2 
pH Percentage hydrogen 
PI  Propidium iodide 
p moles/ml    Pico moles per millilitres 
PRR Pattern recognition receptors 
PVDF  Polyvinylidenedifluoride 
RPM  Revolutions per minute 
SDS-PAGE    Sodium dodecyl sulphate polyacrylamide gel electrophoresis 
SVGp12 Human fetal glial cells 
TEMED          Tetramethylethylenediamine 
xi 
 
TLR2       Toll-like receptor 2  
TLR4       Toll-like receptor 4  
TNF-α     Tumour necrosis factor-α 
Tris Hydroxymethyl 
JNK  C-Jun N-terminal kinase 
 
1 
 
ABSTRACT 
 
Introduction: Innate immune responses are important for brain tissue injury and repair. This 
study tested the innate responses of the neuroblastoma (IMR32) and the astrocytoma 
(SGVp12) cell lines and primary mixed glial CNS cells in vitro to virulence factors from 
Porphyromonas gingivalis ATCC 33277 and 53978 (W50).  
Methods: Following treatment of each cell line, the morphological responses were examined 
using fluorescein-phalloidin labelling and recorded using the confocal microscope. Binding 
of two specific endotoxins to cells were determined by immunolabelling with anti-P. 
gingivalis (clones 1B5, and 1A1) antibodies to LPS, and its specific receptor CD14, and 
gingipains. The Bioplex magnetic bead array analysis from Bio-Rad was performed to 
measure cytokine release by the human cell lines (IMR32 and SVGp12). In addition a second 
ELISA assay specifically for TNF- release was also employed with the same samples.  
Results: All cells abundantly expressed the CD14 receptor on their surface membrane and it 
responded to the P. gingivalis endotoxins rapidly by forming cell surface membrane “blebs” 
at multiple sites. Only prolonged incubation with the virulence factors displayed gingipains 
localised to perinuclear and lysosomal regions of SGVp12 cells and the primary mixed glial 
CNS cells. The fluorescein-phalloidin indicated considerable cell detachment and alterations 
in their actin cytoskeletal filaments from both W50 and 33277. IMR32 confirmed the 
presence of the CD14 receptor by immunoblotting and reflected changes in its protein levels 
with endotoxins from W50 and 33277. For example, treatment with P. gingivalis 33277 
endotoxins, IMR32 cells completely lost their CD14 receptor, but was partially retained after 
exposure with endotoxins from P. gingivalis W50. Similarly, changes were noted with IL-8 
chemokine secretion after SGVp12 cells were exposed to P. gingivalis W50 and not with P. 
gingivalis 33277. Proinflammatory cytokines IL-6 and TNF- remained at their physiological 
levels following treatment of SGVp12 cells to P. gingivalis W50 and 33277. Recurrent 
exposure of SGVp12 cells to endotoxins from P. gingivalis 33277 were tested whereby IL-8 
acted as a marker of acute phase inflammation. However, the acute phase chemokine did not 
significantly change over and above the control samples.  
Conclusions: All cell types responded to the LPS endotoxin, via the CD14 phagocytic 
receptor to bind LPS to the surface membrane and gingipains was generally internalised. 
IMR32 cells completely lost CD14 upon endotoxin treatment possibly cleaved and degraded 
by gingipains. Only P. gingivalis W50 was able to induce the secretion of IL-8 in SVGp12 
cells. Literature suggests IL-8 mediates the recruitment and activation of neutrophils in 
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inflamed tissues. In the same way, IL-8 induction following exposure to P. gingivalis W50 in 
astrocytes would result in the activation and recruitment of microglia to the site of 
infection/injury in the brain with the appropriate virulence of the microorganism. The results 
indicate P. gingivalis W50 which is more pathogenic in comparison to P. gingivalis 33277 
use different means of innate immune mechanisms for survival in the host.  
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1. General Introduction 
 
1.1 Origins of the concept for research 
 
In 1891, Willoughby D. Miller coined the words “focal infection” in his publication in the 
Dental Cosmos journal. He implied that a focal infection involved the microbes and their 
virulence factors from the “foci” of oral microbial infections affecting teeth, mobilise from 
the mouth and may be responsible for causing infections elsewhere in the body (Miller, 
1891). Almost a decade later, the English physician, William Hunter (Hunter, 1900), a strong 
supporter of the concept observed that the origins of caries, pulpal necrosis and periodontitis 
were all microbial and proposed they affected the health of remote body organs such as 
systemic diseases. This phenomenon became accepted as William Hunter‟s “focal infection 
theory” (Hunter, 1900) and his influence had such impact that without the knowledge of the 
exact connection between oral disease and the development of distant organ pathologies, his 
proposal for diseased teeth to be extracted in favour of restoration was accepted by dental 
clinicians worldwide. The contributory factors, as he believed was, surgical intervention 
during diseased tooth restoration in which oral pathogens were being trapped below the 
gingival surfaces and entered the vascular channels via “oral sepsis”. However, several 
decades later the focal infection theory (Hunter, 1900) was re-evaluated and revealed that the 
pathological importance of extracting teeth had little effect on improving systemic health. As 
a consequence, the decision to extract teeth in favour of restoration was reversed in the 
1950‟s.   
There is no doubt that the original concept has left an indelible mark on researchers to 
explore multiple inflammatory pathologies arising from putative immune responses 
originating from oral infections. The hypothesis is broad and a systematic framework of 
research was required to provide proof of concept. To this end, researchers began with 
finding scientific evidence to support the „aetiological hypothesis‟ beginning with the oral 
cavity. Dr Socransky, a pioneer in microbiological and immunological aspects of 
periodontology soon realised that, to answer such a huge scientific question would require 
overcoming many hurdles some of which involved developing new technology. In time, the 
pioneer of periodontology was able to overcome the challenges posed by technology to 
achieve the important milestones such as formulating correct growth culture media and 
conditions of culture (aerobic/anaerobic) for periodontal pathogens under experimental 
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conditions. The proof of the concept for Socransky began to bear fruit in the late eighties 
according to his seminal publication Socransky et al., (1998) and eventually proving the 
Koch‟s postulates for the microbial aetiology of periodontal disease. Whilst some important 
milestones have been achieved to date, others remain elusive. For example, evidence for 
development of remote body organ inflammatory pathologies as hypothesised by Miller 
(1891) and Hunter (1900) attract limited support due to the failure of being unable to satisfy 
the Koch‟s postulates thus far.  
In the meantime, however, scientists began to collect indirect evidence supporting an 
unhygienic oral environment with chronic periodontitis having a negative affect with the 
development of a myriad of diseases. These include cardiovascular (Wu et al., 2000; de 
Oliveira et al., 2010), stroke, aspiration pneumonia (Pihlstrom et al., 2005), renal pathology 
(Craig, 2008), premature birth events (Offenbacher et al., 1996; Lopez et al., 2002), diabetes 
(Grossi and Genco, 1998; Cutler et al., 1999; Taylor and Borgnakke, 2008), respiratory 
diseases (Scannapieco and Mylotte, 1996; Paju and Scannapieco, 2007), rheumatoid arthritis 
(Gleissner et al., 1998; Bartold et al., 2005; Pischon et al., 2008) osteoporosis (Kuo et al., 
2008), pancreatic cancer (Michaud et al., 2007) and cognitive deficit that in some individuals 
progresses to dementia (Kondo et al., 1994; Riviere et al., 2002; Kim et al., 2007; Noble et 
al., 2009 Stein et al., 2007; 2010; 2012).  
 
1.1.1 Experimental advances in favour of the Miller and Hunter concept 
 
In 1998, Socransky et al., identified a consortium of the bacterial species from patients with 
periodontal disease whereby one group of bacteria belonging to the „red complex‟ were 
consistently found. These were Porphyromonas gingivalis, Tannerella forsythia, Treponema 
denticola (Socransky et al., 1998). In the twenty first century, molecular methodologies have 
identified nuclear material from oral specimens from over 500 different bacterial species 
(Paster et al., 2006). As per Miller (1891) and Hunter (1900) hypothesis, scientific evidence 
exists confirming oral bacteria do access the systemic vessels resulting from everyday tasks 
of the oral cavity such as physical trauma from chewing food, tooth brushing, scaling, root 
surface debridement, extractions and periodontal surgery (Carroll and Sebor, 1980; Lofthus et 
al., 1991; Daly et al., 1997; 2001; Kinane et al., 2005; Savarrio et al., 2005; Forner et al., 
2006; Tomas et al., 2007). Specific pathogenic oral microflora represents a potential source 
of infection anywhere in the body.  
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Indirect evidence for bacterial invasion of the arterial tissues has also been established 
with sensitive polymerase chain reaction techniques, sequencing and fluorescence in-situ 
hybridisation (FISH). These have identified genetic profiles of two members of the “red 
complex” periodontal pathogens in the walls of human coronary arterial tissues and atheroma 
(Cavrini et al., 2005; Kozarov et al., 2005; 2006).  
 
1.1.2. Periodontal disease  
 
Periodontal disease (Figure 1.1) is a multifactorial chronic condition involving oral 
pathogens, environmental and genetic elements as well as the host‟s immune system playing 
a predominant role (Haffagee et al., 1988). Influence of the disease is episodic with periods 
of remission and relapse. Although the factors contributing to periods of active/inactive 
disease are not clear, there is consensus amongst clinicians and researchers that the immuno-
inflammatory response within the gingivae and the periodontium (periodontal ligament, 
cementum and alveolar bone) is initiated by a pathogenic bacterial challenge. Gingivitis in 
some individuals has the potential to progress to periodontal disease. However, it is the host‟s 
cellular and molecular interactions initiated by pathogenic bacterial challenge that ultimately 
destroy periodontal tissues (Page and Beck, 1997). Formation of a deepened gingival sulcus 
near the point at which the gingiva makes contact with the tooth is described as a periodontal 
pocket. The depth of the gingival sulcus is determined by inserting a calibrated tool described 
as a “periodontal probe”. Clinically, a probing measurement of more than 3 mm is considered 
as early periodontitis.  
As mentioned earlier, chronic periodontitis (Figure 1.1), in which the individual 
may/may not experience pain, is a progressive and inflammatory oral disease with complex 
aetiology showing genetic and immune susceptibility of the host (Armitage, 1999; Flemmig 
1999; Haffajee et al., 1988). The “red complex” pathogenic bacteria comprising of T. 
denticola, T. forsythia and P. gingivalis (Socransky et al., 1998; Holt and Ebersole, 2005) 
appear to be the main players. Although much more remains undiscovered concerning 
periodontal disease, the aetiology of periodontitis in the context of this thesis has been 
simplified to as being gram negative poly microbial infections of the periodontium (Figures 
1.2a and 1.2b). 
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Figure 1.1: Chronic periodontal disease. Image taken from Pizzo G, et al., (2010) Eur J Intern Med. 
21(6):496-502 shows chronic periodontal disease in a human subject and tooth loss due to the condition. 
 
 
 
 
 
 
 
 
 
 
 
 
The classical inflammatory response of the gingivae during periodontal disease 
 
The periodontal inflammatory response can be described as an initial acute bacterial challenge 
stimulating the junctional epithelium to produce a broad range of inflammatory mediators to 
facilitate both vascular permeability and the influx of neutrophils. The vascular leakage and 
activation of serum proteins begin to amplify the local inflammatory responses and recruit 
monocytes/macrophages and T-lymphocytes. Factors produced by activated macrophages can 
result in the activation of CD4
+
 T-lymphocytes that aid B-cell differentiation locally in the 
gingival tissue with antibody production becoming detectable in the blood serum confirming 
their presence in the body (Haffajee et al., 1995; Kamer et al., 2009; Stein et al., 2012).  
Figure 1.2a: Subgingival pocket with 
bacteria. Subgingival pocket with typically 
10
9 
bacteria. Image taken from Noiri Y et al., 
(2004) J Dent Res 941-5 83(12):941-945. 
 
Figure 1.2b: End stage chronic periodontitis.                                                                            
Radiograph of an end stage chronic periodontal 
pocket as indicated by arrow heads and a bracket  
0.5m 
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All three of the aforementioned red-complex organisms possess known virulence 
factors of which dentilisin, tannerpains and gingipains respectively are a class of proteolytic 
enzymes (Curtis et al., 1999; Holt and Ebersole, 2005 Paramonov et al., 2005), which affect 
the tooth supporting structures (gingiva, periodontal ligament, cementum and alveolar bone). 
High inflammatory burden can alter the balance between the osteoclast-osteoblasts in favour 
of bone loss (Assuma et al. 1998). Alternatively, bone formation can be down regulated via 
tumour necrosis factor-α (TNFα) and interleukin-6 (IL-6) expression by the infiltrated 
macrophages and T lymphocytes (Baker et al., 2000). As bone resorption progresses, the 
tooth becomes mobile within its socket and eventually falls out.  
P. gingivalis is the best-studied (Lotufo et al., 1994) example of periodontal 
pathogens as it has long been implicated in chronic and severe adult periodontitis (Slots and 
Listgarten, 1988). It has an armoury of virulence factors (Holt and Bramanti, 1991; Curtis et 
al., 1999; Paramonov et al., 2005) that destroy matrices anchoring teeth. The trigeminal 
cranial nerve endings that lie close to the teeth may provide a direct pathway for their access 
to the brain as is reported for the Treponema species (Riviere et al., 2002) and via the 
vascular channels as originally implied by the founders of the concept (Miller, 1891; Hunter, 
1900).  
The criterion for investigating responses of central nervous system (CNS) cells to P. 
gingivalis virulence factors was based on an on-going PhD research project which discovered 
LPS from this pathogen in the brain tissue from a validated diagnoses of Alzheimer‟s disease 
(AD) subjects (Poole et al., unpublished data).  
 
1.1.2.1. Porphyromonas gingivalis 
 
P. gingivalis is a member of the black pigmented Bacteroides genus of bacteria (Figure 1.3) 
which are anaerobic, gram negative, non-motile, non-spore forming rod shaped that produce 
dark brown-black colonies on blood agar solid medium (Mayrand and Holt, 1988). The 
organism was reclassified by Shah and Collins, in 1988, into a new genus termed 
Porphyromonas which includes three different species of bacteria. These are P. gingivalis, P 
asaccharolyticus and P. endodontalis. Of these P. gingivalis is associated with chronic 
periodontal disease (Slots and Genco, 1984). 
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Figure 1.3: Ultrastructure of P. gingivalis. An electron microscopy micrograph of P. gingivalis ATCC 33277, 
Bar = 100nm. Image taken from Grenier and Mayrand (1987), Infection and Immunity, 55(1):111-117.  
 
1.1.2.2. Virulence factors of P. gingivalis 
 
A number of virulence factors are associated with P. gingivalis strains of pathogenic bacteria 
which help the organism to destroy host‟s oral surfaces. These include the proteolytic 
enzyme, gingipains, LPS, outer membrane vesicles, short chain fatty acids (butyric and 
propionic acids).  
 
Gingipains  
Gingipains has long been recognised for its trypsin like enzyme activity (Mayrand et al., 
1980; Slots, 1981). It was first purified and characterised from the bacterial capsule 
(Yoshimura et al., 1984) and subsequently in the outer membrane (Fujimura and Nakamura, 
1987). It is now referred to as gingipains (Holt and Ebersole, 2005) and is known to degrade 
fibronectin and collagen.  
 
 
 
 
 
10 
 
Lipopolysaccharide and outer membrane vesicles 
LPS is the major component of the outer membrane of all bacteria. The LPS from Gram 
negative bacteria can exert biological effects by stimulating host cells to produce bioactive 
inflammatory mediators that destroy the host tissues. The gram negative periodontal 
pathogens continuously undergo surface membrane modification in which small outer 
membrane vesicles (Figure 1.4) are released (Grenier and Mayrand, 1987). These are in the 
nanoparticle size (20-200 nm in diameter) range and also contain gingipains (Duncan et al., 
2004). The vesicles contribute towards their biofilm colonisation as well as entering the 
extracellular milieu due to their small size (Schooling and Beveridge, 2006). They also 
contain biologically active components that initiate innate immune responses (Manning and 
Kuehn, 2011). LPS is an example of pathogen-associated molecular patterns (PAMP). 
PAMP‟s are not expressed by the host but are found exclusively in bacterial cell walls 
enabling host cells to distinguish between “self” and “non-self”.  
 
 
   
 
Figure 1.4: High resolution image of the outer membrane vesicles. High resolution transmission electron 
microscope image of the outer membrane vesicles shed by P. gingivalis ATCC 33277. Bar = 100nm. Taken 
from Grenier and Mayrand (1987), Infection and Immunity, 55(1):111-117  
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Short chain fatty acids  
P. gingivalis also releases by-products of its metabolism such as butyric and propionic acids. 
Apart from contributing to the noxious smell, they inhibit fibroblast proliferation (Singer and 
Buckner, 1981) and are toxic to lung fibroblast cells in culture (Van Steenbergen et al., 1982; 
Touw et al., 1982; Grenier and Mayrand, 1985). All these virulence factors permit greater 
tissue destruction and disease progression. 
One consequence of Hunter‟s proposal of total tooth extractions may be the result of 
the discovery by Kondo et al., (1994), linking missing teeth with dementia in a Japanese 
elderly population. Dementia is a complex condition in which individuals develop poor 
memory and progressive decline in overall mental function without the loss of consciousness 
(Lishman, 1978), of which AD is an example. A subsequent longitudinal study by Stein et al., 
(2006) found a statistically significant association with missing teeth due to periodontal 
disease and mental health in a group of women belonging to a religious order (Stein et al., 
2006). The exact connection between missing teeth due to chronic periodontitis and 
deteriorating memory is not resolved. However, further reports from Stein et al., (2012) 
suggest that the titre of circulating antibodies to multiple periodontal pathogens in the elderly 
individual may represent an indicator of a potential risk factor for developing cognitive 
deficit during advancing age with potential in some cases to progress to dementia.  
Periodontitis and AD, share several important features in that, they are both 
progressive and have an important inflammatory component (Haffagee et al., 1988; Akiyama 
et al., 2000). Additionally, both diseases have complex aetiologies including interactions 
between systemic infections (oral pathogens, bronchopneumonia and urinary tract infections), 
immunosenescence, aging and genetic factors (D‟Aiuto et al., 2004; Engelhart et al., 2004; 
Noble et al., 2009; Kim et al., 2007; Hajishengallis, 2010). However, unlike periodontal 
disease, AD does not show signs of remission and relapse as once the memory is lost, it does 
not return.  
Since LPS is the principal initiator of host innate immune responses, it is likely that 
during life, there is potential for this PAMP to initiate inflammation in the aging CNS. 
Additionally, literature supports the view that LPS initiated inflammation in the brain can 
accompany learning and memory impairment (Tanaka et al., 2006; Chen et al., 2008) but, 
without the knowledge of the exact mechanisms involved. There is only one report having 
investigated the effect of LPS from P. gingivalis on primary rodent astrocytes in-vitro 
(Shapira et al., 2002) in relation to multiple sclerosis (a demyelinating disease). However, 
unlike multiple sclerosis, neurodegenerative disorders of which aging is a major risk factor 
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show glial cell activation. Hence this investigation was needed to understand the effects of 
the virulence factors from periodontal pathogens related to specific glial cell responses. This 
project utilised the P. gingivalis, American Type Culture Collection (ATCC) (ATCC 33277 
and ATCC 53978 - W50) whereby both organisms are on the opposite end of the spectrum 
for their low to high pathogenicity. In addition the all-important biological tools (virulence 
factors and antibodies) essential for this study were accessible.  
 
1.2 Aging, structure and function of the Central Nervous System 
and neuro-inflammation 
 
1.2.1 General Introduction 
 
As people grow older, they begin to experience “senior moments” that reflect temporary or 
benign memory loss. One downside of deteriorating memory is the loss of social values as the 
benign state can switch in favour of disease. Numerous studies indicate changes taking place 
in the aging brain. For example the brain weight decreases with age but the cause of 
reduction remains unclear. The volume of the brain in the 8th decade is reduced by 6%-10% 
as compared with the third decade. The age related changes are more prominent in the frontal 
lobe which shows a 10% reduction in volume and 15% reduction in cortical thickness. The 
corpus callosum is decreased in volume by 12-17%, with accentuation in the anterior 2/5th 
because of the reduction of fronto-temporal inter-hemisphere fibers. 
At the cellular level there are phenotypic changes in the brain such as the activated or 
the inflammatory status of glia. What is not clear is, if these changes are due to faulty 
functioning of the innate immune system (immunosenescence) predisposing the senior 
individuals to microbial infections (Caruso et al., 2009; Hajishengalis, 2010) or if intra-
cerebral derived abnormal proteins are contributing to local inflammation. One hypothesis 
links high inflammatory burden in the elderly to deteriorating memory (Holmes et al., 2003; 
Dunn et al., 2005; Holmes et al., 2009). In order to understand the impact of inflammation in 
the aging brain, it is necessary to understand the anatomy and the basic neurobiology of the 
CNS. 
The CNS consists of the brain and the spinal cord which are constantly bathed in the 
cerebrospinal fluid (CSF) secreted by the choroid plexus. The CSF provides nutrients and 
cushions the brain from mechanical shock. The CNS consists of gray and white matter. The 
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gray matter contains cell bodies of neurons, and white matter mainly being, myelinated 
axons.  
 
1.2.1.1 The Brain 
 
The brain is separated by a deep midline which is known as the longitudinal cerebral fissure 
into two cerebral hemispheres. In the depth of the fissure, across the midline, the hemispheres 
are connected to each other by a thick bundle of nerve fibers called the corpus callosum. The 
brain is highly folded to increase the surface area of the gray matter. These folds are known 
as gyri and are separated from each other by indentations known as sulci.  
      Each cerebral hemisphere has four lobes which are defined according to lateral, medial 
and inferior surfaces of the brain (Figure 1.5).  
 
 
   
 
 
Figure 1.5: Schematic presentation of a human brain hemisphere. The schematic image showing the lateral 
view of a brain hemisphere whereby the different lobes are colour coded for ease of identification. (Image taken 
from Kahle and Frotscher, 2003) 
 
The frontal lobe 
The frontal lobe is located behind the forehead and is the largest of the four lobes. It occupies 
the anterior of the cortex and controls the ability to reason, plan, comprehend an idea or 
action and adapt to new situations.  
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The parietal Lobe 
The parietal lobe is located at the top and rear of the brain. It is concerned with perception of 
stimuli related to touch, pressure, temperature and pain. Damage to this lobe may lead to a 
person becoming unfamiliar with parts of their body. 
The temporal Lobe 
The temporal lobe is just above the ear canal and controls hearing. For this reason, it is 
sometimes called the auditory cortex. Some functions of the temporal lobe are perception and 
recognition of auditory stimuli (hearing) and memory (hippocampus). Damage to this area 
can result in hallucinations, aphasia, and loss of language. 
The occipital Lobe 
The occipital lobe of the brain is located at the rear of each hemisphere. It is concerned with 
many aspects of vision. Damage to the occipital lobes can result in blindness.  
The cerebral cortex 
The hemispheres are completely covered by the cerebral cortex and are composed of gray 
matter. It is estimated that the brain as a whole contains around 100 billion neurons and at 
least a 100 trillion synapses. Some neurons make synapses with more than 10 thousand 
different neurons.  
The prefrontal cortex is one of the areas believed to participate in learning and 
memory (Wickelgren, 1979; Damasio, 1989; Squire, 1992) alongside of the hippocampus. 
Exactly how the two areas connect the processes involved with learning and memory 
formation are complex, but anatomically, the hippocampus is joined to rest of the cortex by 
the subiculum.  
 
Hippocampus  
 
The hippocampus belongs to the limbic system (Figure 1.6a) and is also one of the regions 
believed to play important roles in long-term memory and spatial navigation.  
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Figure 1.6a: An overview of major limbic system structures in the brain.  Location of major limbic system 
structures in three-dimensional form within the whole brain. 
 
 
 
Figure 1.6b: Anatomical regions associated with the hippocampus. Schematic diagram to show the essential 
anatomical regions associated with the hippocampus                                  
 
The hippocampus is an elongation of the edge of the cerebral cortex. It can be 
distinguished as a zone where the cortex narrows into a single layer of very densely packed 
neurons. The structures that line the edge of the cortex make up the limbic system (Figure 
1.6a). These include the hippocampus, cingulate cortex, olfactory cortex, and amygdala. The 
hippocampus has been likened to a seahorse (Cornis ammonis) and the subdivisions CA1 
through to CA4 refer to Cornis ammonis 1-4 regions containing pyramidal neurons (Figures 
1.6b and 1.7).  
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Figure 1.7: Hippocampus: the brain region responsible for memory. Tissue section from a mouse brain 
showing the hippocampus and its associated histological features which are labelled 
 
An overview of memory 
Memory is a functional entity of the brain and its biological measure is “long term 
potentiation” (Bliss and Lomo, 1973). These scientists first described the process in the 
hippocampus where neurons “learned” following repetitive electrical stimulations via the 
perforant pathway of the dentate gyrus granular cells (Bliss and Lomo, 1973). Following high 
frequency electrical stimulation, Bliss and Lomo (1973) observed an increase in the 
excitatory post-synaptic potential amplitude of the dentate granule cell population. This 
increase in the efficacy of synaptic signalling has been related to memory as it can vary in 
duration from minutes to hours (Abraham et al., 2002). 
 
1.2.2. Cellular neurobiology 
 
1.2.2.1. The nerve cell function and structure 
 
There are approximately 100 billion neurons in the brain (Johnson and Erner, 1972) which 
originate from the ectoderm during embryogenesis (Allen and Barres, 2009). A neuron 
consists of a cell body (the soma), processes called dendrites which are the fine extensions. 
These convey information towards the soma from synapses on the dendritic tree. The primary 
role of dendrites is to increase the surface area for synapse formation allowing integration of 
a large number of inputs which are relayed to the cell body. Neurons have one main process 
called the axon (Figure 1.8) which originates at the axon hillock and is the most excitable part 
of the neuron due to the high density of sodium channels and is also the part where the action 
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potential is initiated (Eccles, 1964). The cell membrane is also an important component of the 
neuron as ion channels, neurotransmitter receptors and ion pumps are located within the lipid 
bilayer (Klymkowsky and Stroud, 1979; Poulter et al., 1998; Stroud et al., 1990). Neurons 
are highly specialized for intercellular communication involving the propagation of an action 
potential down a neuronal axon to a presynaptic terminal. At the presynaptic terminal the 
signal leads to depolarization of membrane and release of neurotransmitters to receptors on 
the postsynaptic membrane of another neuron. This step is followed by a depolarization of 
this second neurons, and further propagation of the signal (Allen and Barres, 2009).  
 
 
 
 
 
 
 
Figure 1.8: A peripheral nerve and its basic anatomical features. Basic structure of a neuron (peripheral 
nervous system). Image as taken from http://www.google.co.uk/images; re-Notes on biological foundations of 
behaviour. 
 
Most neurons contain Nissl substance which is mainly composed of ribosomes and 
polysomes (Singhrao and Nair-Roberts, 2010). Neurofilaments maintain the cytoskeletal 
architecture of the neuron. Microtubules and microfilaments provide for the flow of the 
axoplasm and for axonal elongation.  
 
The synapse  
The synapse is a highly specialised structure between a presynaptic nerve terminal and a 
postsynaptic neuron as indicated in figure 1.9. Synapses can vary in size and a typical 
synapse in the CNS is composed of a presynaptic nerve terminal and a synaptic cleft which 
physically separates the nerve terminal from the postsynaptic membrane (Figure 1.9). A 
chemical (neurotransmitter) is released from the presynaptic terminal and is captured by 
Axon hillock 
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specific receptors in the post synaptic membrane where it is processed, integrated and 
propagated by the nerve cell into meaningful information.   
 
 
Figure 1.9: A transmission electron microscope image of a synapse. Image from 
http://www.google.co.uk/images. A schematic diagram directly below the electron microscope image shows the 
synapse in relation to the overall cell anatomy (image from http://www.google.co.uk/images). Some labels 
added. 
 
Chemical messengers 
Neurotransmitters are chemicals released at a synapse by presynaptic neurons that affect the 
postsynaptic cell in a specific way. They are stored in synaptic vesicles to protect them from 
enzymatic degradation. There are two types of synaptic vesicles known as small clear-core 
type which are around 50nm in diameter and these are triggered by single action potentials. 
The larger dense core vesicles 100nm in diameter are released by burst firing or repetitive 
stimulation and include the bio-amine and neuropeptide group of neurotransmitters. To 
prevent neurons from being overloaded, there are inhibitory and excitatory synapses. The 
most abundantly expressed neurotransmitters in the nervous system are acetylcholine 
(London et al., 1995; Perry and Kellar, 1995; Perry et al., 1999) glutamate (McGeer and 
McGeer, 1975; Lindefors et al., 1989; Nair-Roberts et al., 2008), dopamine (Lindefors, 1993; 
Nair-Roberts et al., 2008), serotonin (Monsma et al., 1993; Plassat et al., 1993; Ruat et al., 
1993) and gamma amino butyric acid (GABA) (Balcom et al., 1975; McGeer and McGeer, 
1975; Singhrao and Nair-Roberts, 2010). 
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Glutamate is the most abundant neurotransmitter in the brain and is important in 
regards to memory and learning. It is the major excitatory neurotransmitter and is toxic to 
neurons if present in excess. Dopamine is an inhibitory neurotransmitter, meaning it blocks 
the tendency of a neuron to fire an action potential. Dopamine is associated with motivation 
and addiction.  
GABA is an inhibitory neurotransmitter and individuals lacking GABA in their brain 
tend to suffer from anxiety disorders and epilepsy. Serotonin is an inhibitory neurotransmitter 
and is linked to emotions, wakefulness and temperature regulation. Acetylcholine has many 
functions one of these being related to AD due to lower activity of the enzyme choline 
acetyltransferase (Bowen et al., 1976; Davies and Maloney, 1976; Perry et al., 1977). All 
these neurotransmitters appear to be inter-related and have relevance to memory. 
 
Neurotransmitter receptors 
When released, the neurotransmitter is captured by a specific receptor in the postsynaptic 
membrane. Some common examples of receptors are n-methyl-D-aspartate (NMDA) 
receptors (Decker et al., 2010
a and b
), and alpha-amino-3-hydroxyl-5-methyl-4-isoxazole-
propionate (AMPA) (Hsieh et al., 2006) and kainate receptors (Agrawal and Evans, 1986). 
These receptors respond to the glutamate neurotransmitter (Lacor et al., 2004; 2007). Others, 
for example, the nicotinic acetylcholine receptor (nAChR) responds to acetylcholine 
neurotransmitter (Seguela et al., 1993; Wada et al., 1989).  
In vivo animal studies provide evidence for the importance of the neurotransmitter 
receptors in the hippocampus in memory performance and is linked to high densities of 
nicotinic receptors, particularly 7 and 42 subunits (Seguela et al., 1993; Wada et al., 
1989). If these receptors are blocked experimentally with the non-selective nicotinic receptor 
antagonist mecamylamine, memory and long term potentiation become impaired (Kim and 
Levin, 1996; Welsby et al., 2006; 2009). Similarly either the 7 nicotinic receptor 
anatagonist methyllycaconite or the 42 nicotinic receptor antagonist dihydro--
erythroidine can have detrimental effects on the working memory (Addy et al., 2003). 
Conversely, nicotine improves cognitive performance in age-associated memory impairment 
(White and Levin, 2004). Postsynaptic receptors are trans-membrane proteins that adsorb 
released neurotransmitters at its binding site. This induces a conformational change and 
opens an ion channel directly or indirectly. The opening of ion channels on the postsynaptic 
cell causes a change in the excitation of the cell bringing about brief electrical responses 
20 
 
called “synaptic potentials”. The activated receptor can only return to its resting state once 
the neurotransmitter has been removed either by enzymatic hydrolysis (e.g. cholinesterase) or 
re-uptake into the presynaptic nerve terminal or cleared by glial cells (e.g. GABA).  
Glia 
Astrocytes, microglial cells, oligodendrocytes, ependymal cells are the non-neuronal support 
cells collectively called glia. Astrocytes and microglia are of significant interest to 
researchers investigating any aspect of neurodegenerative diseases as they contribute to the 
developing inflammatory pathology.  
Ependymal cells 
Ependymal cells are located strategically at the boundary between the CSF and the brain. The 
ependymal cells express phagocytic receptors, including the mannose receptor and TLRs 2 
and 4 (further examples of PRR‟s) to detect and clear bacteria (Cserr et al., 1992; Stahl and 
Ezekowitz, 1998; Laflamme and Rivest, 2001; Husemann et al., 2002). 
 
Differences between astrocytes and microglia 
 
Astrocytes 
These are the most common type of glia found throughout the CNS. Deiter (1865) is credited 
with the earliest description of astrocytes. Astrocytes are derived from ependymoglia of the 
developing neuronal tube (Abbott et al., 2006). Morphologically astrocytes have oval or 
irregular nuclei with an open chromatin pattern and stellate morphology with numerous fine 
processes radiating in all directions. Astrocytes are of two main types, fibrillary and 
protoplasmic. Fibrillar astrocytes can be demonstrated by immunostaining with glial fibrillary 
acidic protein (GFAP) (Bignami et al., 1972) and the protoplasmic astrocytes using anti-
metallothionine antibody E9 (Neal et al., 1996).  
Following injury, activated fibrillary astrocytes become hypertrophic with increased 
amounts of cytoplasm and express higher levels of GFAP protein. Their increased numbers in 
the area of injury and hyper-expression of GFAP protein constitutes astrogliosis possibly 
from cytokines being released by microglia.  
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Microglia 
Microglial cells were first identified by silver impregnation techniques by Rio-Hortega in 
1919. These are small cells scattered throughout the CNS. Depending on their functional 
properties, microglia display different morphologies where the quiescent (ramified) 
phenotype, is typified by long branching processes attached to a small cell body (Ransohoff 
and Perry, 2009; Hanisch and Kettenmann, 2007). This phenotype represents a reservoir of 
non-activated microglia within the CNS. Microglia can become activated by a variety of 
factors including physical injury, pro-inflammatory cytokines, LPS and inflammatory 
macromolecules. Once activated microglia undergo several key morphological changes 
including thickening and shortening of branching processes attached to a hypertrophic cell 
body to adopt the characteristic morphology of activated microglia (Perry et al., 2010). 
Astrocyte cell function  
The astrocytes are responsible for the maintenance of homeostasis in the micro-environment 
of the neurons. For example, they are implicated in the formation and stabilisation of 
neuronal synapses (Ullian et al., 2001; Christopherson et al., 2005; Allen and Barres, 2009). 
They also participate in metabolic pathways which modulate the transport of ions, release of 
transmitters, metabolites. Astrocytes are recognised for their function in maintaining the 
blood brain barrier (BBB) (Nedergaard et al., 2003) and maintaining tight control of local ion 
and pH homeostasis, glucose levels and metabolic substrates (Nedergaard et al., 2003; 
Ransom et al., 2003).  
The blood brain barrier and immuno privilege of the CNS   
 
Figure 1.10:  Schematic showing the intact blood brain barrier. The section in the transverse plane shows 
the blood brain barrier is composed of endothelial cells, pericytes and astrocytes. Image is taken from Stam R 
(2010) published in Br Res Rev 80-97. 
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In health, the CNS is an immune privileged organ that maintains a physical BBB through the 
endothelial cells in capillaries (Figure 1.10). The tight endothelial cell junctions offer high 
electrical resistance and foot processes of astrocytes tightly cover capillary openings to the 
brain protecting neurons from extrinsic insults. This way the CNS retains its 
immunosuppressive microenvironment that keeps naive T cells and plasma proteins/toxins 
out. The intact BBB also prevents microglial cell activation as the result of systemic antigens 
such as LPS, gaining unrestricted access to the brain parenchyma.  
Astrocytes react to injury by adopting the “activated” morphology (Figure 1.11). The 
reactive fibrillary astrocytes engage in secondary phagocytic activities (al-Ali and al-Hussain, 
1996; Nguyen et al., 2011) and can also be considered as antigen presenting cells second in 
line to microglia.  
 
Figure 1.11: Reactive astrocytes in a disease condition. Reactive astrocytes from AD brain stained with anti-
GFAP following immunoperoxidase/Diaminobenzidine method. The activated phenotype is whereby the soma 
of the cell has become enlarged and their fibrillary projections dilate. Image = x20 objective on a light 
microscope. 
The reactive astrocytes (Figure 1.11) can switch on differential expression of multiple genes 
compared to the non-reactive astrocyte (Eddleston and Mucke, 1993; Eng and Ghirnikar, 
2000) in which they synthesize some components of the innate immune system (Levi-Strauss 
and Mallat, 1987; Morgan and Gasque, 1996). Astroglioma cell lines have proven to be 
useful models for astrocyte function in vitro and have been used to provide evidence for a 
role in antigen presentation and inflammatory cytokine release in the CNS (Fontana et al., 
1987). Using rat astrocytes and human astrocyte-derived tumour cell lines treated with the 
inflammatory cytokine interferon-gamma (IFN-) have shown these cells to secrete all 
components of the classical and alternative and terminal pathways of the complement system 
(Levi-Strauss and Mallat, 1987; Walker and McGeer, 1993; Morgan and Gasque, 1996). 
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Microglial cell function  
As mentioned earlier, microglia can become activated (Figure 1.12) by a variety of factors 
including physical injury, interaction with pro-inflammatory cytokines, LPS and other 
inflammatory macromolecules. 
 
 
 
Figure 1.12:  Activated microglial cells in a disease condition. Activated microglial cells from AD brain 
stained with HLA DR (clone CR3/DP, DQ, DR) antibody. The activated phenotype of microglia is in which 
they have become enlarged and their processes have become thickened as shown. Image = x20 objective on a 
light microscope. 
 
Brain inflammation, which occurs behind the BBB, therefore differs from inflammation in 
the periphery by the relative absence of leukocytes (including neutrophils, monocytes, B 
cells, and T cells) and antibodies. Nevertheless, microglial cells are key cells contributing to 
brain inflammation. They express a range of proinflammatory interleukin class of cytokines 
(Hanisch, 2002) and are capable of recognising non-self PAMP‟s displayed by bacteria and 
their cellular debris to reduce the inflammatory response. 
 
 
Importance of glial cells in local innate defence mechanism against pathogen entry 
 
As there is no immune surveillance by cells from the classical adaptive immune system, the 
resident glial cells provide a local innate defence mechanism capable of defending the CNS 
against pathogen entry. Most importantly microglia are HLA-class II positive cells capable of 
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antigen presentation as well as expressing CD14, toll like receptors 2 and 4 (TLR-2 and 
TLR4) that recognise PAMP‟s and a range of complement receptors 1, 3 and 4 (CR1, CR3 
and CR4) that identify and phagocytise bacteria (Gasque,  2004). The intrinsically activated 
microglia express de novo immune markers including MHC class II proteins complement 
receptors (CR1, CR3, CR4, TLRs 2 and 4) and pro-inflammatory signalling molecules 
including the complement anapylatoxins (C4a, C3a, C5a) that recruit more activated 
microglia to the site of tissue injury (Laflamme and Rivest, 2001; Gasque, 2004) resulting 
with cytokine synthesis. However, when challenged with systemic LPS, microglial cells 
again demonstrate an activated phenotype capable of mounting a similar innate immune 
response to combat the destructive effects of the extrinsically derived endotoxins. Continual 
exposure of microglia to both, circulating systemic LPS due to concurrent infections such as 
bronchopneumonia, urinary tract and oral infections, together with intra-cerebral infections 
result in the continual activation of microglia and the adoption of a hypersensitive „activated‟ 
phenotype. The LPS hyper-sensitized microglia increase synthesis of inflammatory mediators 
tumour necrosis factor-alpha (TNF-), interleukin-1 (IL-1, and interleukin-6 (IL-6) 
complement factors,TLR-2 and TLR-4 and nitric oxide (NO) that release free radicals and 
reactive oxygen species (Laflamme and Rivest, 2001; Gasque, 2004; Boje and Arora, 1992; 
Lodge and Sriram, 1996; Floyd, 1999; Ye and Johnson, 2001; Godbout et al., 2005) 
increasing the severity of neurodegeneration.  
Numerous studies suggest that advancing age is associated with developing 
inflammatory changes (Letiembre et al., 2007b). It is plausible that the inflammatory status is 
an adaptive immune mechanism during the aging process or a function of advancing age that 
makes elderly individuals more susceptible to infections (Caruso et al., 2009; Hajishengalis, 
2010). Collectively these factors contribute to the development of poor memory (Dunn et al, 
2005; Letiembre et al., 2007b). It is reported that the number of innate immune TLR increase 
in the brain following normal aging in mice (Letiembre et al., 2007a) and similar 
observations are reported from AD brains (Liu et al., 2005; Letiembre et al., 2007b; Walter et 
al., 2007) and in AD transgenic animal models (Fassbender et al., 2004; Letiembre et al., 
2007b; Walter et al., 2007; Wirths et al., 2010; Frank et al., 2009).  
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1.2.2.2. Extrinsic factors contributing to neuroinflammation 
 
Numerous studies have shown that LPS from gram negative bacteria either administered 
directly into the peritoneum, systemic or the brain, all induce neuroinflammation in the form 
of glial cell activation (Cunningham et al., 2005; Godbout et al., 2005; Chen et al., 2008; 
Henry et al., 2009) and where measured, the inflammatory response is accompanied by 
learning and memory impairment (Tanaka et al., 2006; Chen et al., 2008). A different 
investigation evidenced IL-1 secretion following peripheral challenge with LPS (Henry et 
al., 2009). The already activated glia synthesise cytokines (IL-1, tumour necrosis factor-
alpha or TNF-) in response to infection (Cunningham et al., 1996; Henry et al., 2009). Such 
cytokines are implicated in synaptic loss (Bellinger et al., 1993; Yang et al., 2005; Mishra et 
al., 2012) and with reduced long term potentiation (Bellinger et al., 1993; Cunningham et al., 
1996). Although data on the mechanisms in relation to changes in long term potentiation and 
inflammatory burden are sparse, only a few in-vitro methodological studies suggest the 
cytokines exert their effect on the NMDA (Yang et al., 2005) and AMPA (Lai et al., 2006) 
receptors.  
 
Recognition of bacterial lipopolysaccharide (LPS) by innate immune cells 
 
The receptor for LPS is CD14 which is also known as a pattern recognition molecule of the 
innate immune system (Wright et al., 1990) and is a 55-kD glycosylphosphatidyl inositol 
(GPI)-anchored surface glycoprotein (Haziot et al., 1988). It lacks the trans-membrane 
domain and is therefore, unable to initiate intracellular cell signalling. In order to initiate 
intracellular signalling, CD14 requires a co-receptor with the intracellular domain. A family 
of type I trans-membrane TLRs has been identified in humans and mice (Poltorak et al., 1998 
a and b; Arbour et al., 2000). To date, 10 human TLRs appear to function as innate immune 
receptors for LPS and other microbial products (Shimazu, 1999). Of these, TLR-2 (LPS from 
gram positive and TLR-4 from gram negative bacteria) have been reported to function as 
LPS-signalling receptors. 
Following LPS binding to CD14, on myeloid cells, the TLRs initiate intracellular 
signalling cascades that stimulate release of proinflammatory cytokines (including IL-1, IL-6, 
and TNF-α), chemokines (IL-8), nitric oxide synthase and other anti-microbial peptides to 
destroy pathogenic microbes (Han and Ulevitch, 2005). CD14 is abundantly expressed by all 
CNS cells including neurons, astrocytes and microglia (Griffiths et al., 2010). TLRs recruit 
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additional adaptor proteins such as myeloid differentiation primary response gene 88 
(MyD88) (Kawai and Akira, 2007) MD-2 (Shimazu et al., 1999; Nagai et al., 2002) for 
optimal intracellular signalling involving the mitogen-activated protein kinase (MAPK) for 
NF-kB-dependent pro-inflammatory gene expression (Wang et al., 2001; Sanjo et al., 2003; 
Shim et al., 2005) see figure 1.13. 
                               
 
Figure 1.13:  A pathway for the recognition of bacterial lipopolysaccharide. LPS from bacterial membranes 
is transferred to a lipid-binding site on CD14 in the membrane of phagocytes. CD14 promotes the binding of 
LPS to the TLR4-MD2 complex, which initiates intracellular cell signalling. In the absence of CD14, TLR4-
MD2 can still function with some forms of LPS or with much higher LPS concentrations.  
 
 
The immune cells of the CNS also sense the immune challenges presented via the 
blood vascular system using the circumventricular organs and the choroid plexus that are 
devoid of the BBB (Oldfield and Mckinley, 1995). Cells from this region of the brain are 
fully equipped with the CD14 receptor and the TLR-4 to recognise LPS from the peripheral 
blood circulation (Lacroix et al., 1998; Laflamme and Rivest, 2001; Beutler et al., 2003). 
Hence, elements of systemic infections such as those originating from gram negative, oral 
pathogens, bronchopneumonia and urinary tract infections (Holmes et al., 2003; Dunn et al., 
2005, Kamer et al., 2009; Holmes et al., 2009; de Oliveira et al., 2010) reach all organs 
including the CNS. 
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1.3. The Rationale 
 
Dental infection may provide a potential pathogenic and inflammatory link during advancing 
age through its interaction with the CNS innate immune responses. If this is the case, dental 
intervention will be a priority from an early age. 
1.3.1. Aim 
 
The main aim of the study was to determine the responses of CNS cells to direct exposure of 
endotoxins from periodontal pathogens to incite innate immune responses and activate 
astrocyte cells to release acute phase cytokines and chemokines following exposure to the 
culture supernatant of P. gingivalis (ATCC 33277 and W50). Where, P. gingivalis W50 is 
more pathogenic than 33277. 
 
1.3.1.1 Objectives  
 
1. To establish brain cell (cell lines and primary cells) cultures. 
2. Expose cells in culture to the pathogen and its products from any one/or all of the 
three red complex pathogens stated (P. gingivalis (ATCC 33277 and W50) and 
Treponema denticola and Tannerella forsythia).  
3. Measure the cellular responses using immunofluorescence labelling, immunoblotting 
and ELISA assays for cytokine release. 
 
 
1.3.1.2  Research approach  
 
The main methodologies used in this investigation are in vitro cell culture, 
immunofluorescence, immunoblotting and commercial Elisa assays which are fully described 
in the next chapter. 
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Chapter 2: Investigating responses of CNS cells to P. 
gingivalis virulence factors  
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2. Investigating responses of CNS cells to P. 
gingivalis virulence factors 
 
 
2.1 Introduction (in brief) 
 
Aging has an element of neuroinflammation and is viewed in some patients as being a 
precursor for developing dementia. A number of studies suggest the main differences 
between the young and the aged brain (age being a major risk factor for AD) is an imbalance 
in the control of pro-inflammatory mediators especially cytokines (Ye and Johnson, 1999; 
Godbout et al., 2005; Chen et al., 2008; Henry et al., 2009) perhaps due to inflammation 
developing quickly on subsequent exposure to pathogens (Holmes et al., 2003; Dunn et al., 
2005; Godbout et al., 2005) and/or the organ having diminished ability to cope with the 
overwhelming inflammatory burden. This study set out to find evidence for inflammatory 
responses initiated by a periodontal pathogen on CNS cells in vitro. 
 
2.1.1. Materials and Methods 
 
2.1.1.1 List and source of reagents  
 
Control and test spent media for P. gingivalis (ATCC 33277) and (ATCC 53978 - W50) and 
the anti-LPS and anti-gingipains (clone 1B5 and clone 1A1) were a kind gift from Prof. M. 
Curtis and Dr A. Hashim (Centre for Immunology & infectious disease, London, UK). The 
rabbit anti-human GFAP (gift from Dr J. Newcombe, The MS Society, London, UK),  Mouse 
anti-human CD14 (clone HCD14) and rat anti-mouse CD14 from Bio-Legend, Thermo-
Fisher , rabbit anti-PGP 9.5 (UltraClone Ltd, UK), SVGP12 and IMR32 from ATCC, E.coli 
LPS from Sigma Aldrich, UK Normal,  goat serum (X0907) and normal rabbit serum 
(X0902) from DakoCytomation, Germany, Phalloidin-FITC from Molecular probes (UK). 
Anti-T. forsythia antibodies (recombinant bacterial surface protein A (rBspA), gift from Dr 
Sharma, USA), anti-T. denticola antibodies were raised in-house from hybridoma cell lines 
(TDII (HB-9966) and TDIII (HB-9967) purchased from ATCC as per manufacturer‟s 
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instructions. All cell culture media and additives were from Life Technologies Ltd, Paisley, 
UK, encompassing a consortium of companies inclusive of Invitrogen®.  Applied 
Biosystems® · Gibco® · Molecular Probes® · Novex® · TaqMan® · Ambion®. 
IonTorrent®.  Bromodeoxyuridine (Boehringer). Blocking solution 0.01 M phosphate buffered 
saline (PBS) pH 7.3 containing 0.01% normal goat/rabbit serum and 2% tween 20 was prepared in-
house. The Bioplex Pro human cytokine group panel kit (cat no. M50-000007A) was 
purchased from Bio-Rad, UK and TNF- instant ELISA assay (BMS223INST) from 
eBioscience.  
 
2.1.1.2 In vitro culture  
 
Immortalised cell lines cells 
The SV40 immortalised normal human glial cell line SVGp12 was obtained from ATCC ref 
no. CRL-8621 (Manassas, VA, USA) and cultured in Eagle‟s minimal essential medium 
(EMEM) supplemented with heat inactivated 10% foetal calf serum (FBS), 4mM glutamine, 
2mM sodium pyruvate and  0.1 mM non-essential amino acids (NEAA) and without  the 
addition of penicillin/streptomycin (Life technologies Ltd., UK).  
Use of antibiotics in cell culture: The commonly used antibiotics in cell culture experiments 
are penicillin and streptomycin (Pen/Strep). Ideal growth conditions (temperature, humidity 
and growth medium) also encourage the growth of microbial contaminants in incubators. To 
avoid contamination of cells growing at 37C, antibiotics are added to growth media. IMR32 
cells were very sensitive to infection and hence Pen/Strep was added to their general growth 
medium during maintenance of these cells. However, there are rare situations when 
antibiotics can hinder the growth and proliferation of specific cells in culture. The astrocyte 
cell line SVGp12 is an example of such a cell line as it is generally resistant to infection. 
ATCC recommended that this cell line should be cultured in their specified growth medium 
without the addition of antibiotics.  
 
 
 
31 
 
IMR32 
The human neuroblastoma cell line IMR32 was obtained from ATCC ref no. CCL-127 
(Manassas, VA, USA), and cultured in Dulbecco‟s modified essential medium (DMEM) 
supplemented with heat inactivated 10% FBS, 4mM glutamine, 2mM sodium pyruvate and 
100IU/ml penicillin/streptomycin (Life technologies Ltd., UK). 
Primary mixed CNS cell isolation and culture 
Fresh C57/BL6J mice brains from 1 day old pups (N=6, full litter) were collected in Hank‟s 
buffer having sacrificed the animals according to the UK Home Office guide lines and on 
schedule I killing of laboratory animals following approval from the University of Central 
Lancashire‟s animal projects committee (reference number RE/11/07/SS). Rest of the 
procedure was performed under sterile tissue culture conditions as described below. 
Using the aseptic technique, under sterile conditions of a class II tissue culture hood, 
all of the brain tissues were chopped finely using a sterile scalpel blade and collected into a 
50cm
3
 Falcon tube containing Hanks buffer (Life Technologies Ltd., UK) and pelleted by 
centrifugation at 1000 rpm (3 times for 5min). The tissue was digested in 0.05% trypsin (Life 
Technologies Ltd) in Hank‟s buffer made with (10% Hanks‟ balanced salt solution, 0.1M 
Hepes, 0.15% sodium bicarbonate solution at (Life Technologies Ltd), 100 IU/ml 
penicillin/streptomycin, 100g/ml kanamycin, 20 mg/ml gentamycin and incubated at 37C 
for 15 min with constant agitation. The mixture was further treated with DNAse I (0.2g/ml 
final, Sigma Aldrich) for 1 min. The cells were dissociated periodically using a sterile Pasteur 
pipette and eventually re-suspended in DMEM supplemented with heat inactivated 10% FBS, 
4mM glutamine, 2mM sodium pyruvate and 100IU/ml penicillin/streptomycin (Life 
technologies Ltd.,). The cells were filtered through a 70m nylon cell strainer (Becton-
Dickinson) and pelleted by centrifugation at 1500rpm for 20 min. The cell pellet was re-
suspended in fresh DMEM with additives and seeded at 2x10
6 
cells/10ml/T25 culture flasks 
coated with 10mg/ml poly-L-lysine (Sigma). Primary mixed cells were also seeded on coated 
(10mg/ml poly-L-lysine) coverslips. The coverslips were individually placed into 6 well 
plates and 100l of the cell suspension at 1x105 cells was transferred onto each coverslip. 
Incubation and feeding of cells 
All cells were cultured (cell lines, and primary cells) either in flasks (T25) or on sterile 
uncoated/coated glass coverslips placed in six well plates in the presence of appropriate 
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culture medium were incubated at 37C in a humidified atmosphere of 5% CO2, 95% air with 
regular media changes every two-three days where applicable. Following two weeks growth, 
the primary CNS cells were fed in DMEM/F12 medium to encourage microglia. 
Cell passaging 
SVGp12 and IMR32 cell lines were sub-cultured every 4 days in T25 or 75-cm
2
 flasks. Each 
time cells were passaged the medium was removed from the flask and washed x3 with 10 ml 
of sterile phosphate buffered saline solution (PBS) (8g sodium chloride (NaCl), 0.2g 
potassium chloride (KCl), 1.44g disodium mono-hydrogen phosphate (Na2HPO412H20), 
0.24g potassium di-hydrogen phosphate (KH2PO4), made up to a litre with water, pH 7.2). 
After aspirating the PBS, 1ml of x1 solution of trypsin (Life technologies Ltd.,) was used to 
cover the cells and left to stand for approximately 5 minutes at 37C. After checking that 
100% of the cells had rounded up, 9.5 ml of growth medium was added to the flask and all 
the liquid was transferred to a 15 ml centrifuge tube and centrifuged at 1000 rpm. The 
supernatant was aspirated and pellet re-suspended in 10 ml of appropriate growth medium. 
0.8µl of the suspension was pipetted onto a haemocytometer to count cell numbers on a 
microscope. The number of cells in 3 large squares were counted and divided by 3 for the 
number of cells/ml and multiplied by 10 for the total number of cells collected from the flask. 
This way the number of population doublings could be counted. Cells were re-plated at 
around 2.5x10
5
.  
Freezing down of cells for stock maintenance 
After sub-culturing, any cells that were not re-plated were frozen and stored as viable stocks. 
The spare cell suspension was re-centrifuges for 5 minutes at 1000 rpm. After removing the 
supernatant the pellet was re-suspended in 0.5 ml of medium and an equal volume of freezing 
mix (20% dimethyl sulphoxide (DMSO, Sigma), 80% foetal calf serum). The suspension was 
transferred to a freezing ampoule and stored at -80C in a freezing box before being 
transferred to liquid nitrogen for long-term storage. When recovering cells from liquid 
nitrogen the ampoule was thawed and suspension pipetted into a 15 ml centrifuge tube. 10 ml 
of medium was added in a drop-wise fashion and then carefully mixed. The cells were 
centrifuged at 1000 rpm, supernatant removed and cells re-suspended in 10 ml of medium 
and re-plated in a T25 flask. 
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Components in the medium control and their sources 
Medium control in this context refers to the sterile liquid medium containing brain heart infusion 
broth supplemented with haemin (5 mg/l), menadione (1 mg/l), (Sigma-Aldrich, UK) prepared by Dr 
A. Hashim (Centre for Immunology & infectious disease, London, UK).  
Components in the spent medium and their sources 
The spent medium is culture supernatant in which P. gingivalis (ATCC 33277 and W50) were 
optimally cultured for 48h. Following growth, each culture was centrifuged at 15,000 rpm at 4C for 
30 min to pellet bacterial cells and the culture supernatant alone was collected. 1ml or 0.5 ml aliquots 
were prepared in pre labelled sterile Eppendorf® tubes and stored at -80C until needed. Following 
addition of protease inhibitors to one of the aliquots from both the culture supernatant and the sterile 
growth medium (control), they were freeze dried for at least 12h and re-suspended in a 200μl volume 
of lysis buffer containing 50mM Tris pH 8.0, 1% NP40, 150mM NaCl, 5mM EDTA prior to 
determining the total protein concentration. The aliquots were stored at -20C for subsequent analysis 
This too was prepared by Dr A. Hashim and was supplied as a gift reagent, courtesy of 
Professor M. Curtis (Centre for Immunology & infectious disease, London, UK).  
Exposure of cells to P. gingivalis virulence factors 
Following 95% confluent cell growth, the glass coverslips were exposed to total virulence 
factors from P. gingivalis ATCC 33277 and ATCC 53978 - W50 culture supernatant (gift 
source) having initially confirmed the presence of LPS and gingipains by immunoblotting 
using the anti-P. ginigvalis (clone 1B5) in EMEM/DMEM as described above. The optimal 
dilution in growth medium lacking penicillin/streptomycin for all cells determined was ¼, 
and the time points (8h, 12h, 24h and 48h) for specific needs and according to specific cell 
types. Following the specified time for treatment of cells, supernatants were collected and 
stored at -80°C for cytokine analysis using the Bioplex magnetic bead array analysis (Bio-
Rad, UK) and by another ELISA assay for TNF-eBioScience. Cells from T25 flasks were 
used to prepare cell lysates for analysis by immunoblotting and cells on coverslips were used 
for immunofluorescence labeling. 
Repeat-exposure of cells to P. gingivalis virulence factors 
In order to determine the responses of recovered cells to repeat exposure with P. gingivalis 
(ATCC 33277) virulence factors, the detached surviving cells from the first exposure were re-
plated in fresh growth medium. Once they had fully recovered and become adherent, they 
were re-exposed the 2
nd
 and with recovery in between for the 3
rd
 time under the same 
conditions as the first exposure (see above). The recovered cells were examined for their 
responses to LPS and differences in the GFAP and CD14 were noted and compared with their 
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respective controls. The supernatants were collected following each of the treatments as well 
as at the recovery phase and stored at -80°C for cytokine analysis (see above). 
Bromodeoxyunidine incorporation in DNA of dividing cells 
Uptake and incorporation of bromodeoxyunidine (BrdU) during DNA synthesis enables the 
detection of dividing cells in a population. Cells were cultured onto coverslips at 1x10
5
 cells 
and re-fed with EMEM 2 days before the assay. The coverslips were incubated with 
bromodeoxyuridine (BrdU; Boehringer) (50 µmol/l) for 4 hour at 37C.  
Cell fixation 
Following treatment, the cells (on coverslips) were fixed either in 10% neutral buffered 
formalin, or 4% paraformaldehyde in PBS at 4C, ranging from 30 min, 1h to overnight at 
4°C. Following a thorough washing of cells in 0.01M phosphate buffered saline, pH 7.3 
(PBS), the cells were either used immediately or held in PBS for up to 1 week at 4°C.  
 
2.1.1.3. Immunofluorescence labelling 
 
For all in vitro cell cultures   
Controls 
All cells on coverslips acting as controls included omission of the primary antibody or 
inclusion of the anti-P. ginigvalis (clone 1B5 and/or clone 1A1) antibodies on medium-
control challenged cells.  
Note: Anti-P. ginigvalis (clone 1B5) detects both LPS and gingipains whereas  (clone 1A1) is 
specific for gingipains. 
Immunofluorescence localisation of specific cell markers 
Immunolabelling was performed with appropriate antibodies (sources as mentioned above). 
Following fixation (see above) and incubation of cells in the blocking solution containing 
0.01% normal goat and/or rabbit serum/or 1% BSA (bovine serum albumin)/PBS/ 
0.25%tween 20, for 30 min they were incubated overnight at 4°C in either rabbit anti-human 
GFAP at 2g/ml; rabbit anti-PgP 9.5 at 10g/ml solution, goat anti-Iba-1 at 5g/ml diluted in 
blocking solution. Following thorough washes in PBS (3 x for 5 min) in between, secondary 
detection was performed by using goat anti-rabbit or rabbit anti-goat IgG conjugated to FITC 
at 5g/ml in 2% goat serum/PBS/tween20. Following further washes in PBS for 3x 5min, 
cells on coverslips were mounted onto previously labelled glass microscope slides using the 
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Vectashield®-mountant containing propidium iodide (PI). The labelling was repeated at least 
three times for consistency of results. 
Immunofluorescence labelling of anti-P. gingivalis (gingipains and LPS) and the LPS 
receptor CD14 
Non-specific antibody binding to cells was inhibited with a block solution (see above), as for 
specific cell markers, the coverslips were subjected to the following primary antibodies 
mouse anti-human CD14, rat anti-mouse CD14, anti-P. gingivalis (clone 1B5 and 1A1) 
overnight at 4ºC. The detection was performed using the same method as above except the 
following secondary conjugates were used. These were goat anti-mouse IgG conjugated to 
FITC, goat anti-rat alexa flour 488 (molecular probes). Following further washes in PBS for 
3x 5min, cells on coverslips were mounted onto previously labelled glass microscope slides 
using the Vectashield®-mountant with PI as before. The procedure was repeated at least three 
times at each treatment point. 
Treponema denticola and Tannerella forsythia antibodies on bacterial cell smears 
The Treponema denticola and Tannerella forsythia antibodies were tested on appropriate 
bacterial cell smears prepared on glass slides obtained from in-house cultures of the 
periodontal pathogens from another on-going PhD project. Following heat fixation of the 
bacterial smears, they were equilibrated in PBS and blocked prior to incubation in the anti-T. 
forsythia antibodies (gift from Dr Sharma, USA) and anti-T. denticola antibodies raised in-
house from hybridoma cell lines (TDII (HB-9966) and TDIII (HB-9967) from ATCC) as per 
manufacturer‟s instructions. The procedure was the same as that described for the anti-P. 
gingivalis (clone 1B5) antibody mentioned above.  
Fluorescein-phalloidin method for detecting actin cytoskeleton of cells 
Following fixation in 4% paraformaldehyde in PBS for 30 min at 4C. Coverslips were 
washed in PBS and left to equilibrate in PBS for 10 min. The cells on coverslips were 
permeablised in 1% triton x-100/PBS for 5min. Non-specific binding sites were blocked in 
1% BSA (bovine serum albumin)/PBS for 30 min at room temperature. The stock 
fluorescein-phalloidin (Molecular Probes) at 200units/ml was diluted in PBS for 5units/ml 
final concentration and applied to the cells on the coverslip for 30 min in the dark at room 
temperature. Following washes (3x5min each) the cells were mounted onto glass microscope 
slides bearing the appropriate identification and examined using the 510 series Zeiss confocal 
microscope (Carl Zeiss Ltd). The labelling was repeated at least three times for each 
treatment. 
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Assessment of BrdU incorporation 
Once the protocol was optimised, the assay was repeated just once for each of the repeat 
treatments. Following labelling (4h), cells were washed in PBS and then fixed in 4% 
paraformaldehyde/PBS for 30 min at 4C. Coverslips were washed and left to rehydrate in 
PBS for 15 min. Cells were permeabilised for 20min in 0.2% triton-100/PBS at room 
temperature followed by washing in PBS. Endogenous fluorescence was quenched for 15 min 
in 50mM glycine/PBS. Coverslips were washed and left to rehydrate in PBS for 15 min. Each 
coverslip was incubated at 37C, with sheep anti-BrdU polyclonal antibody (Abcam ab1893) 
diluted 1:100 +2.5l DNAse I/100l volume of diluted antibody, in the incubation buffer 
(66mM Tris, 0.66mM ~MgCl2, 1mM 2-mercaptoethanol, pH 8.2) for no longer than 2h. 
Following further washing in PBS each coverslip was incubated with rabbit anti-sheep IgG 
conjugated to FITC (Abcam ab6743) diluted (1/100) in 1% BSA /PBS for 50 min at room 
temperature. Following further washes with PBS, the coverslip was mounted onto a glass 
microscope slide using the Vectashield-PI mounting medium as before.  
Tunel assay 
FragEL™ DNA Fragmentation Detection Kit 
To assess if the detached cells were apoptotic cell bodies, they were centrifuged smeared onto 
a pre-labeled microscope glass slides and fixed in 10% formalin 4°C. They were analysed 
using the fluorescent version of the FragEL™ DNA Fragmentation Detection Kit according 
to manufacturer‟s instructions (Calbiochem). This assay is a non-isotopic system for labelling 
of DNA breaks in apoptotic nuclei. Detection and analysis of labelling was by fluorescence 
microscopy at least twice on cells from three different sets of experiments.  
 
2.1.1.4. Biochemistry 
Confirming the presence of P. gingivalis (ATCC 33277 and W50) supernatants for LPS and 
gingipains virulence factors 
On receipt of the medium control and the spent medium from Dr A Hasim (see above) on ice 
1ml or 0.5 ml aliquots were prepared under sterile conditions in pre labelled sterile 
Eppendorf® tubes and stored at -80C until needed. Following addition of protease inhibitors 
(leupeptin, aprotinin, pepstatin) were used to one of the aliquots from medium control and the 
spent medium from two different strains of bacteria to inhibit the endogenous biological 
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activity (i.e. cleavage of peptide bonds) which would otherwise lead to false positive results. 
The contents of the three tubes were freeze dried for 12h and re-suspended in a 200μl volume 
of lysis buffer containing 50mM Tris pH 8.0, 1% NP40, 150mM NaCl, 5mM EDTA prior to 
determining the total protein concentration. The aliquots were stored at -20C for future 
analyses. 
Escherichia coli control LPS  
Commercially prepared (phenol extracted) lyophilized powder from E. coli LPS was obtained 
from Sigma Aldrich (UK) and re-suspended (1mg) in 250μl lysis buffer containing protease 
inhibitors used above and stored at -20C. 
Cell lysate from in vitro culture of SVGp12 and IMR32 cells 
Following exposure of cells to either the medium-control or to P. gingivalis spent media 
SVGp12 and IMR32 cells were pelleted and washed twice in cold sterile PBS with 
centrifugation (5 min at 2,500rpm). The cells were lysed in buffer containing 50mM Tris pH 
8.0, 1% NP40, 150mM NaCl, 5mM EDTA and protease inhibitors (Roche, UK). Following 
incubation on ice for 30 min and frequent vortex mixing, the cell homogenate was 
centrifuged at 12,000 rpm for 20 min at 4C in a micro-centrifuge (Eppendorf, UK). The 
supernatant was collected in pre-labelled tubes and stored at -20C.  
Protein assay 
Total protein concentration of all cell lysates was determined using the Bradford colorimetric 
assay (Bradford, 1976). Briefly, protein concentration was obtained from a standard curve 
prepared using 100-400 mg/ml bovine serum albumin (BSA) diluted in lysis buffer. 
Following addition of Coomassie blue (Sigma Aldrich, UK) to all standards and test samples; 
absorbance was measured at 595 nm wavelength using the Jenway 7315 spectrophotometer. 
The concentration of the unknowns was calculated by comparing absorbance values with the 
standard curve. 
Sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) 
A mixture of proteins from appropriate samples was separated by SDS-PAGE (Laemmli, 
1970). The separation is based on protein size measured in kilo Daltons (kDa). Lower 
percentage gels (for example, 6%) are better at resolving larger proteins, whereas higher 
percentage gels (10-15%) are better for smaller proteins. The separated proteins can be 
visualised by transferring the proteins from the gel matrix onto a nitrocellulose membrane for 
immunoblotting using the appropriate antibodies to detect proteins present at low 
concentrations. 
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Stock buffers for gels and the associated reagents. 
Non-reducing Laemmli sample buffer (catalogue no. 161-0737) was purchased from BIO-
RAD UK. 
BIO-RAD Sample buffer (reducing): 5% -mercaptoethanol (Sigma Aldrich) added to the 
non-reducing sample buffer (as above). 
Upper buffer or stacking gel buffer: 0.5 Tris base and 0.4% SDS, pH 6.8. 
Lower buffer or separating gel buffer: 1.5M Tris base and 0.4% SDS, pH 8.8. 
Freshly prepared 10% aqueous ammonium persulphate (APS, Sigma Aldrich). 
30% acrylamide/0.8% N, N‟-methylene bisacrylamide stock solution and prestained protein 
markers (GE Healthcare and Lonza). 
NNN‟N‟-tetramethylethylenediamine (TEMED, Sigma Aldrich). 
Electrophoresis or running buffer x10 stock: glycine 144g, Tris base 30g/litre of distilled 
water and 0.1% SDS, pH 8.3. 
 
 
2.1.1.5. Casting gels and SDS-PAGE  
Using the apparatus from the Bio-Rad mini gel electrophoresis system, glass plates (short 
plate and spacer plate) were cleaned with 70% Ethanol and assembled ready in the stand for 
receiving the appropriate percentage gel. The required percentage gels were cast using the 
stock reagents according to the table below enough for making up two gels (Table 2.1). 
Table 2.1: Stock reagents for different percentage gels for two gels 
Reagents Resolving Gel Stacking Gel 
 10% 12.5% 4% 
40% 
bisacrylamide 
3.83 ml 4.53 ml 575 µl 
1M Tris HCl, pH 
8.8 
3.63 ml 3.63 ml - 
1M Tris HCl, pH 
6.8 
- - 1.3 ml 
10% SDS  100 µl 100 µl 50 µl 
10% APS 75 µl 75 µl 37.5 µl 
dH20 7.05 ml 6.35 ml 4.075 ml 
TEMED 15 µl 15 µl 7.5 µl 
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The lower or separating gel was poured first to a specified level and overlaid with 70% 
methanol until set. The methanol was washed away with distilled water prior to pouring the 
upper or stacking gel. Combs were inserted to create 10 sample loading wells to hold 
approximately 20l volume each. Whilst waiting for the gels to set, pre-stained protein 
markers (GE Healthcare) and all samples (30µg/lane) were prepared in sample (Laemmli) 
buffer containing 5% -mercaptoethanol and heated (heat block) for 5 min at 90C.   
Following complete polymerisation, the gels were connected to the Bio-Rad 
electrophoresis unit as per manufacturer‟s instructions (Bio-Rad Laboratories Ltd, UK), and 
1x electrophoresis buffer was added. The combs were removed and 20l of each sample was 
loaded into each of the wells using fine and long tips whilst making sure not to let the sample 
overflow into the next well. Order of each sample loaded was recorded and electrophoresis 
was performed at 100 volts until the bromophenol dye front was about 1 cm from the bottom 
of the gel. 
Electro-transfer of proteins onto nitrocellulose membrane 
Buffers: Stock transfer buffer (x10: glycine 144g, Tris base 30g/litre of distilled water, pH 
8.3) was diluted 1/10 in distilled water to which was added methanol (10% final in the 
transfer buffer). The nitrocellulose blotting membrane used was immobilon-P polyvinylidene 
difluoride (PVDF) membrane (Millipore UK Ltd.,) and required hydration and equilibration 
in transfer buffer prior to use. This was accomplished by placing the membrane in methanol 
for 30 sec and then into transfer buffer for around 2h on a shaking device. 
 The electrophoretic transfer of the separated proteins in SDS-PGE gels was performed 
in the Bio-Rad trans-blot transfer cell (Bio-Rad Laboratories Ltd). The following “sandwich” 
– sponge, moist filter paper (Sigma), moist PVDF membrane, gel, moist filter paper, sponge 
all held within a plastic cassette were placed into the transfer tank. The electrodes of the cell 
were connected so that the proteins transferred from the gel (+ve) to the membrane (-ve). The 
transfer was performed for 2h at a current between 180-200mA. 
Immunoblotting   
Immunoblotting of all presented results was performed at least three times to confirm the 
reproducibility of the results. Successful transfer was immediately noted by the presence of 
pre-stained molecular weight markers on the membrane. Following an initial incubation of 
the membrane in 5% non-fat milk/PBS for 30min at room temperature using gentle mixing on 
a Stuart spiramix roller mixer (Fisher Scientific), the membranes were incubated overnight at 
4C in at least 10mls of appropriate dilution of the primary antibody diluted in 5% milk/PBS. 
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Next day, the membrane was briefly washed in distilled water followed by extensive 
washings (3x 15 min each) in PBS/0.1% tween20. A further incubation of the blot for 2h at 
room temperature with horse radish peroxidase (HRP) conjugated goat anti-mouse or rabbit 
secondary detection antibody (Chemicon) in 5% non-fat milk/PBS as described in Table 2.2. 
The membrane was again briefly washed in distilled water followed by extensive washings 
(3x 15 min each) in PBS/0.1% tween20. The blots were developed at varying intervals using 
the enhanced chemiluminescence (ECL) system (Bio-Rad, Laboratories, UK) under ultra 
violet light in a gel-doc (Bio-Rad, UK) imaging station using the Molecular Analyst software.  
 
Table 2.2: Shows the conditions and the antibodies and their dilutions used for 
immunoblotting 
Protein Percentage gel Primary secondary 
P. gingivalis LPS 
and gingipains 
12.5% 
Reducing conditions 
1B5 (1/20) Goat anti-mouse-
HRP 1/20,000 
P. gingivalis 
gingipains 
12.5% 
Reducing conditions 
1A1 (1/50) Goat anti-mouse-
HRP 1/20,000 
CD14 12.5% 
Reducing conditions 
CD14 1/1000 Goat anti-mouse-
HRP 1/20,000 
Rabbit anti-GFAP 12% Reducing 
conditions 
1/250 Goat anti-rabbit-
HRP 1/80,000 
 
SVGp12 and IMR32 cells  
Electrophoresis of SVGp12 and the IMR32 cell samples was also carried out under reducing 
conditions as described above at 30µg total protein concentration. 
 
ELISA assays for human cytokines  
These were performed only once due to the high cost of the commercial assays. Cytokines 
which were secreted in response to the virulence factors by the in vitro human cell line 
(SVGp12 and IMR32) cultures were detected by analysing the supernatants collected from 
SVGP12 cells and IMR32 following treatment with P. gingivalis ATCC 33277 and W50 at 
24h. Initially the human TNF- instant ELISA assay (BMS223INST) from eBioscience was 
performed following manufacturer‟s instructions. Subsequently, the Bioplex Pro human 
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cytokine group panel kit (cat no. M50-000007A) was purchased (Bio-Rad). The target 
cytokines were the following interleukins (IL), IL-2, IL-4, IL-6, IL-8, IL-10, Granulocyte 
macrophage colony-stimulating factor (GM-CSF), interferon-gamma (IFN-γ) and TNF-alpha 
(TNF-). The bioplex bead array automated system (Bio-Rad) was used as per 
manufacturer‟s instructions. 
 
2.2 Results 
 
2.2.1. SVGp12 a model cell line 
 
The human foetal astrocyte cell line SVGp12 is adherent (Figure 2.1) and in general 
refractive to bacterial infections and this allows it to be cultured under conditions that do not 
require antibiotics. SVGp12 cell line was cultured in appropriate growth medium with 
supplements and was checked by using phase contrast microscopy (Figure 2.1). SVGp12 
cells are adherent cells with population doubling approximately every 2.5 days. Cells used for 
each treatment were at least 95 % confluent. 
 
   
 
 
  
 
 
 
 
Figure 2.1: The SVGp12 adherent cell monolayer in culture. The cells imaged under phase contrast 
microscopy. SVGp12 cells were actively dividing (arrows pointing to mitotic bodies), bar =50 microns. 
  
 
 
 
 
 
 
42 
 
2.2.1.1.  Immunofluorescence 
 
If, antibiotics were added, the population doubling time become retarded (data not shown) 
and cells appeared stressed (Figure 2.2) as demonstrated by fluorescein-phalloidin method for 
labelling polymerised actin.  
Controls  
All control cells remained negative wherever the primary antibody was omitted (Figures 2.2a, 
2.3a, 2.4a, 2.17a, 2.24a) or when the primary antibodies (anti-P. gingivalis, clones 1B5 and 
1A1) were applied to medium-control challenged cells or (naïve = completely unchallenged) 
cells (Figures 2.5a, 2.6a, 2.10a, 2.11, 2.19, 2.20a 2.25a). 
The Treponema denticola and Tannerella forsythia antibodies on bacterial cell smears 
Anti-T. forsythia antibodies raised to rBspA protein, and the anti-T. denticola antibodies only 
weakly labeled the whole bacterial cells (not shown). Further experiments using these 
antibodies were terminated at this stage as distinction between the true signal and the 
background autofluorescence signal was difficult to appreciate when applied to test cells.  
 
  
Figure 2.2: Effect of antibiotics (pen/Strep) on SVGp12 cell lines in culture. SVGp12 cells labelled with 
fluorescein-phalloidin a) control, b) grown under antibiotic free conditions in and c) showing stress filaments 
when antibiotics were included in their medium.  
Ideal growth conditions provided by incubators also encourage the growth of contaminants in 
culture flasks if sterility is breached during culture. To limit contamination antibiotics are 
added to growth media. However, there are rare situations when antibiotics can hinder the 
growth and proliferation of specific cells in culture. The astrocyte cell line SVGp12 is an 
example of such a cell line. For example, the application of antibiotics on SVGp12 cell line 
demonstrated stress filaments (Figure 2.2 c) and the population doubling time was much 
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slower in the antibiotic included medium compared with the medium without antibiotics (5 
days to become confluent instead of 2.5 days).  
Astrocytes were identified by the cell marker antibody known as the glial fibrillary acidic 
protein (GFAP). To investigate whether the SVGp12 cell line was from astrocyte origins, 
anti-GFAP was applied to these cells. Fluorescent staining clearly demonstrated the 
intracellular staining of GFAP positive intermediate filaments in SVGp12 cells (Figure 2.3).  
 
Figure 2.3: SVGp12 cells showing astrocyte cell specific proteins. There is a central nucleus showing 
several nucleoli (arrows) in a) and b) labelling with mouse anti-GFAP antibody diluted 1/100. GFAP detects 
intermediate filaments (green). Intermediate filaments form networks that provide support to cells.  
 
Astrocytes express CD14 receptor protein which acts as co- receptor to interact with bacterial 
LPS. To determine whether the CD14 receptor on SVGp12 cell line is responsive to the effect 
of bacterial endotoxin, its protein was analysed by immunofluorescence. Fluorescent staining 
clearly showed SVGp12 cells expressed copious amounts of CD14 receptor protein (Figure 
2.4) on the surface membrane as expected. 
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Figure 2.4: SVGp12 cell line expresses the surface membrane receptor, LPS. SVGp12 cells a) control b) 
labelled with mouse anti-human CD14 (1/100) to show they express the LPS receptor on their surface 
membrane (green).  
To determine the effect of the endotoxins from periodontal pathogen, P. gingivalis on 
different CNS cell types, initially, the SVGp12 cell line was exposed to the endotoxin. One 
noteworthy feature was the detachment of cells from the plastic on which they were growing. 
The effect of gingipains was determined from a few cells that remained attached (Figure 2.5). 
Gingipains in these cells was internalised and compartmentalised into lysosomes as shown in 
figure 2.5. 
 
Figure 2.5: Intracellular localisation of gingipains in SVGp12 cell line. SVGp12 cells labelled with mouse 
anti-1A1 (anti-gingipains), a) no green labelling was observed when anti-P. gingivalis antibodies (clones 1A1) 
was applied to SVGP12 control medium treated cells. Following treatment with P. gingivalis 33277, 32h cells 
b) labelled with mouse anti-1A1 and the labelling was mainly peri-nuclear and appeared within lysosomes. 
The effect of the endotoxins on the cell morphology and mechanism of self-modification 
from the toxic effect was investigated on SVGp12 cells. The results demonstrated LPS 
binding caused perturbation of the cell membrane in the form of “blebs” as immunolabelling 
was largely observed in ruffled membrane surfaces (Figures. 2.6 and 2.7).  
The anti-P. gingivalis antibody clone 1B5 supported the localisation of two different 
virulence factors and these were due to the shared epitope between LPS and gingipains 
recognised by this antibody. Figure 2.6 demonstrates that if cells were exposed to the 
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virulence factors for over 24h, both LPS and gingipains were detected as surface and 
intracellular antigens. 
 
Figure 2.6: Specific response of SVGp12 cells to endotoxins (LPS). SVGp12 cells a) control whereby no 
green labelling was observed when anti-P. gingivalis antibody (clone 1B5) was applied to SVGP12 control 
medium treated cells, b) labelled with mouse antibody anti-P. gingivalis clone 1B5 that detects epitopes for LPS 
and gingipains. Following treatment with P. gingivalis W50, and b-c) 33277 for 24h, various morphological 
changes were observed.  
Compared with control cells, the effect of the endotoxin on actin protein in SVGp12 cells was 
rounding of cells with enhanced phalloidin labelling and thickened filaments which passed 
through the nucleus of the detached cells (Figure 2.7c). The thickened filaments are an 
indication that cellular stress is experienced by cells during exposure to the endotoxins.  
  
Figure 2.7: Morphological responses of SVGp12 cells to endotoxins. The effect of the LPS from P. 
gingivalis 33277 on the actin cytoskeleton was observed using the fluorescein-phalloidin marker (green). 
SVGp12 cells a) medium control showed the normal flattened cell morphology and normal distribution of actin 
filaments. Spent medium from P. gingivalis 33277 1:4, over 24h showed b-c) detached cells which had rounded 
up. Image c) also shows actin filaments passing through the nucleus of the detached cells. 
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Following treatment of SVGp12 cells with P. gingivalis 33277, 24h, CD14 protein synthesis 
appeared to be much reduced as demonstrated by immunofluorescence labelling (Figure 2.8).  
 
 
Figure 2.8: CD14 receptor protein on SGVp12 cell following challenge with endotoxins. SVGp12 cells 
labelled with mouse anti-CD14 following treatment with P. gingivalis 33277, 24h. The nuclei appear atypical, 
being pushed to one side of the rounded cell and CD14 protein has decreased compared with their initial culture 
shown in figure 2.4b. 
 
Assessment of BrdU incorporation following repeat endotoxin challenge 
Following multiple challenges with the endotoxins, one out of three sets of different 
experiments revealed that the SVGp12 cells were proliferating faster and their population 
doubling increased at the 2
nd
 challenge to 1 population doubling/day (Figure 2.9). This 
observation was further supported by BrdU labelling whereby more cells (56%) were labelled 
by the antibody (proliferating) in the treated cells at the second challenge than the controls 
(48%). Following the third challenge, the cells appeared more and more like fibroblasts and 
BrdU labelling was not performed as the population doubling time indicated no further 
changes taking place in the rate of proliferation. 
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Figure 2.9: Monitoring proliferation following endotoxin repeat-exposures on SVGp12 cells. SVGp12 
cells 2
nd
 challenge with Pg33277 initiated proliferation, labelled with BrdU following 3
rd
 consecutive treatment 
with P. gingivalis 33277, 24h with recovery in between shows little change in proliferation since the 2
nd
 
challenge, but morphology appears to be of more slender, fibroblast like cells. 
Following multiple challenges with the endotoxins, the SVGp12 cells (not quantified) 
appeared smaller in size and slender in shape (figures 2.10 and 2.11). GFAP protein levels 
were much reduced compared with their untreated controls following recovery (Fig 2.10). 
  
Figure 2.10: Change in GFAP protein on SVGp12 cells in between endotoxin challenges. SVGp12 cells 
2
nd
 challenge with Pg33277 showed GFAP levels decreased markedly. A) control with primary antibody 
omitted. However, recovery of cells (2 passages later) b) returned GFAP levels. The cells generally appeared 
smaller and slender. 
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Similarly, multiple challenges of the same cells to the endotoxins also affected the cell size 
and CD14 protein levels compared with their untreated controls (Figure 2.11). 
 
Figure 2.11: CD14 receptor on SVGp12 cell surface membrane in between exposures to endotoxins. 
Repeated insult with the endotoxin followed by recovery in between showed these cells were able to re-express 
CD14.  
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Immunoblotting of SVGp12 cells 
The many different virulence factors present in the P. gingivalis spent medium that was used 
to challenge the cells was initially separated by electrophoreses on the SDS-PAGE gels 
(12.5%). Once the proteins were transferred onto the PVDF membrane, anti-P. gingivalis 
(clone 1B5) detected LPS and gingipains. As mentioned earlier, the antibody is unique in 
detecting two different proteins that share the same epitope. The lane 1 shows no band as it 
contains control medium, number of bands are present in lane 2 where, the darker band 
corresponds to gingipains and laddering bands corresponds to LPS, lane 3 shows no band as 
it contains LPS from E. coli, this demonstrates the specificity of the anti-P. gingivalis 
antibody across different bacterial species. Lane 4 shows no bands as it contains SVGp12 
cells that were untreated and hence the neoepitope for LPS and gingipains is absent. Lane 5 
shows the upper band corresponds to gingipains and the lower bands correspond to LPS 
adsorbed by the cells in figure 2.12.  
 
Figure 2.12: SVGp12 cells adsorb LPS. Immunoblot 20 μg of total protein/lane was loaded on a 12.5% 
SDS-PAGE gel and transferred onto the PVDF membrane. The membrane was incubated overnight at 4 °C in 
primary antibody anti-P. gingivalis (1B5, diluted 1/20) followed by secondary antibody (goat anti-mouse 
conjugated with HRP 1/20,000). Note the anti-P. gingivalis (clone 1B5) has detected both gingipains and LPS 
from the treated cells. 
The medium control (lane 1), E. coli LPS (lane 3) and the cells treated with medium control (lane 4) failed to 
produce any bands whereas the positive control culture supernatant (lane 2) shows a number of bands. The 
darker bands above 52 kDa size correspond to gingipains (lane 2) and all the bands in a laddering pattern (34-12 
kDa sizes) correspond to LPS as confirmed in a). The result in lane 5 confirmed the de-novo antigen detected by 
the aforementioned antibody was due to LPS in the culture supernatant having an effect on SVGp12 cells.  
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Western blotting to detect gingipains on challenged SVGp12 cells. 
Anti-P. gingivalis (clone 1A1) detects gingipains only (Figure 2.13). Lanes 1-5 are the same 
as those shown in figure 2.12 except only a few bands were observed in the positive control 
(lane 2) and in the test cells (lane 5). These bands correspond to gingipains. The reasons for 
the lower position of the band in lane 5 as compared with the higher band in lane 2 may be 
due to gingipains having been degraded by the living cells.  
 
Figure 2.13: SVGp12 cells internalise gingipains. Immunoblot 20 μg of total protein/lane was loaded on a 
12.5% SDS-PAGE gel and transferred onto the PVDF membrane. The membrane was incubated overnight at 4 
°C in primary antibody (1A1, diluted 1/50) followed by secondary antibody (goat anti-mouse conjugated with 
HRP 1/20,000). The medium control (lane 1),   E. coli LPS (lane 3) and the cells treated with medium control 
(lane 4) failed to produce any bands whereas the positive control culture supernatant (lane 2) shows at least 2 
bright bands representing gingipains from the spent medium. The darker bands around the 58 kDa size 
correspond to gingipains (lane 5) from SVGp12 cells. The reasons for the lower band in lane 5 as compared 
with the higher band in lane 2 may be due to gingipains having been degraded by the living cells. 
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A western blot was also performed with anti-GFAP antibody (Figure 2.14) which 
demonstrated the protein syntheses was perturbed by the endotoxin treatment of SGVp12 
cells as compared with the control treated cells.   
 
Figure 2.14: Intermediate filaments are perturbed in SVGp12 cells following an endotoxin challenge. 
SVGp12 cells showing immunoblotting with anti-GFAP following treatment with 33277 and W50 supernatants. 
GFAP is a monomeric molecule with a molecular mass between 40 and 53 kDa  
Immunoblot 20 μg of total protein/lane was loaded on a 12.5% SDS-PAGE gel and transferred onto the PVDF 
membrane. The membrane was incubated overnight at 4 °C in primary antibody (GFAP diluted 1/250) followed 
by secondary antibody (goat anti-mouse conjugated with HRP 1/20,000). A weak band was detected (lane 1) in 
the lysate prepared from SVGp12 cells growing in culture. No bands were detected (lanes 2 and 3) and treated 
with spent medium from P. gingivalis 33277 and W50. A weak band was detected from the cell lysate prepared 
from SVGp12 cells treated with medium control.  
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Cytokine release analyses  
ELISA assays were performed some of which required plotting a standard curve from a set of 
standards with known concentration that were supplied in the kit (The eBioscience instant 
ELISA kit). 
 
 
Figure 2.15: Standard curve for the TNF-α instant ELISA. Standard curve was plotted to calculate the 
concentration of the cytokine TNF- released by SVGp12 cells under specified culture conditions in the 
eBioscience instant ELISA. 
Concentrations of the TNF- cytokine were calculated from the standard curve shown in 
figure 2.15. The results from the eBioscience instant ELISA for TNF-, detected the cytokine 
at physiological levels in the SVGp12 cells are presented in Table 2.3. 
Table 2.3: The eBioscience instant ELISA showing concentration of the released TNF- 
eBioscience instant ELISA  Concentration 
pM/ml 
Sample ID TNF- 
SVGp12, med-control 1:4, 24h 38.58 
 SVGp12, W50 1:4, 32h 14.58 
SVGp12, 33277 1:4, 24h 53.58 
 
 
 
 
y = 0.005x + 0.0629 
R² = 0.9931 
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Analysis of cytokines using the Bioplex bead array 
Numerous cytokines which were secreted in response to the virulence factors by the SVGp12 
and IMR32 cells in vitro were detected (Table 2.4) using the bioplex bead array automated 
system (Bio-Rad). The Bioplex Pro human cytokine group panel kit (cat no. M50-000007A) 
was purchased just once (Bio-Rad). The target cytokines were the following interleukins (IL), 
IL-2, IL-4, IL-6, IL-8, IL-10, Granulocyte macrophage colony-stimulating factor (GM-CSF), 
interferon-gamma (IFN-γ) and TNF-alpha (TNF-).  
 
Table 2.4: The Bioplex bead array ELISA (supernatant following a 24h exposure)  
Bioplex bead array (pM/ml 
Sample ID IL-6 IL-8 IL-10 IFN- TNF- 
SVGp12, med-cont, 1:4, 24h 521.83 995.87 0 0 0 
SVGp12, W50, 1:4, 24h 298.73 1299.5 0 0 0 
SVGp12, 33277 1:4, 24h 34.67 160.27 0 0 0 
 
IL-2, IL-4 (not shown), IL-10, IFN-γ, TNF-, were all undetected by the Bioplex bead array 
system. GM-CSF was also detected in the medium used as control at equivalent levels (not 
shown). IL-6 secretion was within the physiological range. An important feature of these 
cells following endotoxin challenge particularly to the P. gingivalis W50 was the clear up-
regulation of the chemokine IL-8.  
Repeat exposures 
The second exposure of the same surviving cells with the P. gingivalis 33277 showed they 
released IL-8 cytokine but was not sufficiently different from the values recorded for control 
supernatants (Table 2.5). Two different ELISA assays revealed these cells secrete IL-6 at 
physiological levels and is not sufficiently up-regulated above these levels during the 
endotoxin challenges on SGVp12 cells. 
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Table 2.5: The Bioplex bead array ELISA following repeat exposure to endotoxins 
Bioplex bead array 
(pM/ml 
Sample ID IL-6 IL-8 IL-10 IFN- TNF- 
SVGp12, med only (or 
control) 1:4, 24h after 1
st
 
passage 
24.02 995.87 0 0 0 
 
 
SVGp12, treated 33277 
1:4, 24h 
34.67 160.27 0 0 0 
 
SVGp12, med only (or 
control) after 2
nd
 passage 
33277,1:4, 24h 
55.1 483.1 0 0 0 
 
 
SVGp12, 33277 med 
after 3
rd 
treatment 1:4, 
24h 
42.65 289.1 0 0 0 
 
 
 
Following repeat treatments of SVGp12 cells with the P. gingivalis 33277 spent medium, IL-
8 was not up-regulated as shown.  
2.2.2. IMR32 a model cell line 
In sharp contrast to the SVGp12 cell line, the human neuroblastoma cell line IMR32 is semi-
adherent with a polygonal shaped morphology under phase contrast microscopy. Antibiotics 
were essential during in vitro culture conditions (Figure 2.16). The cells used for the 
treatment were at least 95 % confluent. 
 
 
 
 
Figure 2.16: Appearance of IMR32 cells under phase contrast. IMR32 Monolayer showed low adhesion 
to the tissue culture plastics. Bar = 50 microns 
 
 
 
55 
 
2.2.2.1.Immunofluorescence 
 
IMR32 cells expressed neuronal cell marker protein (anti-PgP9.5) as shown in figure 2.17b. 
This immune marker was mainly intracellular and localised to the soma. These cells also 
demonstrated the presence of the CD14 receptor by immunolabelling with anti-CD14 (Figure 
2.17c). 
 
 
 
 
Figure 2.17: Neuronal origins of the IMR32 cells and detection of the LPS receptor. General 
characteristics of IMR32 cells compared with a) control (no primary antibody included) showed the presence of 
b) PgP9.5 (1/200) neuron cytoplasmic protein (green), a marker of neurons on a monolayer of 24 h culture c) 
anti-CD14 1/100 marker detects CD14 phagocytic lipopolysaccharide (LPS) receptor protein (green).  
 
Labelling IMR32 cells from normal growth conditions with phalloidin (Figure 2.18 a) 
revealed their fine processes that were not detected by immunolabbelling with anti-PgP9.5 
(Figure 2.17). Due to their semi-adherent properties, these cells reacted very quickly and 
withdrew their processes when antibiotics were omitted during the medium control treatment 
(Figure 2.18 b).   
 
Figure 2.18: IMR32 cell line expresses actin. Fluorescein-phalloidin labelling detected the actin 
cytoskeletal protein (green) in IMR32 cells a) monolayer in growth medium shows long processes of the cells b) 
in growth medium without the antibiotics and addition of P. gingivalis growth medium (1:4) showed the cells 
beginning to show stress. 
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It was not possible to determine the localisation of gingipains on IMR32 cells as they 
detached instantly following addition of the P. gingivalis 33277 endotoxins (Figure 2.19). 
Therefore, longer exposure of these cells to the endotoxin was not performed. 
 
 
 
Figure 2.19: Gingipains is not internalised by IMR32 cell line. IMR32 cells labelled with mouse anti-1A1 
(anti-gingipains) following treatment with medium control. Cells treated with P. gingivalis 33277, showed these 
cells did not internalise gingipains at early time (8h post exposure). 
 
The effect of IMR32 cells upon short exposure (6h) to endotoxins from P. gingivalis 33277 
appeared to be related to LPS (Figure. 2.20) as the various morphological changes in these 
cells were common to those described for SGVp12 cells. Some of the IMR32 cells adsorbed 
LPS and other cells began to detach from the flask and round up.  
FragEL™ DNA Fragmentation assay demonstrated no apoptotic cell death in the detached 
cells following exposure to the P. gingivalis endotoxins. The positive control generated by 
DNAse I treatment showed the assay was working as all the nuclei were labelled green (data 
not shown). 
Furthermore, the floating cells were collected and re-introduced to culture in their respected 
medium where they flattened and began to grow as shown in figure 2.20.  
   
Figure 2.20: Morphological responses of IMR32 cells to endotoxins (LPS). IMR32 Cells challenged for 
6hs with a) medium control failed to detect P. gingivalis LPS and within 6h IMR32 cell line exposed in vitro to 
virulence factors from periodontal pathogens P. gingivalis 33277 demonstrated b) LPS adsorbed at the cell 
surface.  At 24h exposure c) 95% of the cells lost their protoplasmic extensions, rounded up and detached from 
their plastic/glass substrate as shown by fluorescein-phalloidin labelling. The floating cells d) were collected and 
re-introduced to culture in their growth medium where they flattened out and began to grow. 
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Immunoblotting for CD14 receptor 
 
Immunoblotting was performed on cell lysates prepared from IMR32 cells following 
exposure to control and test endotoxins for 24h. They were separated by SDS-PAGE 
electrophoresis as described for the anti-P. gingivalis antibodies (clones 1B5 and 1A1). The 
data revealed that the CD14 receptor protein was present on control cells but upon challenge 
with P. gingivalis 33277 the receptor completely diminished. Treatment of the same cells 
with W50 strain surprisingly, only partially decreased it (Figure 2.21) as compared with the 
controls. 
 
 
Figure 2.21: IMR32 cells lost CD14 receptor protein following an endotoxin challenge. Immunoblot 
performed with 20 μg of total protein/lane on a 12.5% SDS-PAGE gel and transferred onto the PVDF 
membrane. The membrane was incubated overnight at 4 °C in primary antibody (anti-CD14 diluted 1/1000) 
followed by secondary antibody (goat anti-mouse conjugated with HRP 1/20,000). The IMR32 cells grown 
under standard tissue culture growth conditions (lane 1), confirmed the abundant expression of the CD14 
receptor on these cells. There was no effect on the CD14 expression when the cells were treated with medium 
control (lane 2). E. coli LPS (lane 3) and the cells treated with P. gingivalis 33277 supernatant (lane 4) failed to 
produce any bands whereas the cells treated with P. gingivalis W50 (lane 4) showed a reduced band for CD14.  
 
Cytokines release analysis 
Any cytokines which may have been secreted in response to the virulence factors by IMR32 
cells in vitro were analysed using the eBioscience instant ELISA assay and the Bioplex bead 
array automated system (Bio-Rad). Both assays confirmed that the IMR32 cells did not 
secrete any of the analysed cytokines (Tables 2.6 and 2.7).  
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Table 2.6: Data from the eBioscience instant ELISA assay for TNF-α (24h treatment)   
Sample ID TNF-pico moles/ml 
IMR32, med-control 1:4, 24h 0 
IMR32, W50 1:4, 24h 0 
IMR32, 33277 1:4, 24h 0 
 
Analysis of TNF- cytokine using the eBioscience instant ELISA assay shows these cells did 
not secrete the named cytokine. (All cytokine values = pico moles/ml) 
The Bioplex bead array system: cytokine assay 
 
Table 2.7: The Bioplex bead array ELISA assay for IMR32 (24h interval)  
Sample ID IL-6 IL-8 IL-10 IFN- TNF- 
IMR32, med-cont 1:4, 24h 0 0 0 0 0 
IMR32, W50 1:4, 24h 0 0 0 0 0 
IMR32, 33277 1:4, 24h 0 0 0 0 0 
 
The Bioplex bead array shows IMR32 neuroblastoma cell line was unable to secrete any of 
the cytokines in the presence of P. gingivalis W50 following primary endotoxin challenge. 
 
Primary CNS mixed cell culture 
 
The primary CNS cells were all adherent cells which lacked any neuronal cell growth as 
observed under phase contrast microscopy (Figure 2.22).  
59 
 
 
Figure 2.22: Phase contrast images from primary CNS mixed cell culture. These were adherent cells 
with various morphologies (a-c), bar =50 microns  
 
In order to identify the cell types in the mixed CNS cell culture, glial cell marker antibodies 
were used. The microglial cell marker Iba-1 failed to demonstrate the presence of these cells 
in culture although bunches of astrocytes (Figure 2.23) were often present as identified by 
immunolabelling with the anti-GFAP antibody.  
 
  
Figure 2.23: Astrocytes were present in the mixed primary cell culture. Primary astrocytes from the CNS 
mixed culture labelled with rabbit anti-human GFAP as shown in a-b.  
 
To determine whether the CD14 receptor on primary cells was expressed immunolabelling 
was performed with an antibody raised to the mouse CD14 (Figure 2.24). Although, it 
identified cells expressing the LPS receptor but their identity was not evaluated by double 
immunolabelling. The CD14 positive cells were abundant in culture.  
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Figure 2.24: Mixed primary cells express the LPS receptor. Primary CNS cells a) control whereby the 
primary antibody is omitted and b) labelled with rat anti-mouse CD14. 
 
Following addition of the P. gingvalis 33277 endotoxins the primary mixed cells reacted in a 
similar way as the SVGp12 and IMR32 cells described above. Due to the limited supply of 
these cells and time restraints, further responses were not examined. 
 
Figure 2.25: The response of primary cells to endotoxins (LPS). Primary CNS cells challenged with a) 
medium control and b) spent supernatant from 33277, 1:4 for 24h. Both images are labelled with 1B5. 
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3. General Discussion 
 
 
 
Chronic adult periodontitis has been associated with several conditions and of importance 
here is deteriorating memory which in some patients progresses to dementia. Chronic 
periodontitis is a condition caused by numerous periodontal pathogens in which P.gingivalis 
is strongly implicated (Socransky et al., 1989). There is growing evidence that an unhygienic 
oral environment with chronic periodontitis can negatively affect mental health (Noble et al., 
2009). However, knowledge of the exact risk factor giving rise to cognitive deficit that in 
some individual‟s progresses to dementia is limited. Around 40% of the population over 85 
years are likely to be affected with AD and another 25% in which it is combined with the 
effects of cardiovascular disease (www.alz.org/downloads/facts_figures_2012.pdf - United 
States). Periodontitis is of early onset although its true consequences are felt with advancing 
age. Around 10-15% of the adult population develops severe, chronic periodontitis (Preshaw 
et al., 2012). 
Neurodegenerative disorders of which aging is a major risk factor show elements of 
neuroinflammation, meaning the inflammatory response is that of resident brain glial cell 
activation. There are two main hypotheses to explain how this takes place in the brain. 1) An 
inter-cerebral stimuli, such as physical trauma, accumulation of abnormal proteins (amyloid 
beta) and direct infections. 2)  Inflammatory stimuli from extra-cerebral sources including all 
forms of systemic infections once the BBB is breached. Specific pathogenic oral bacteria 
responsible for periodontitis also infiltrate into the systemic circulation and are a potential 
source of infection/inflammation in the brain.  
In this respect, Miller (1891) and Hunter (1900) hypothesis for oral bacteria being 
able to participate in distant organ inflammatory pathology by accessing the systemic vessels 
appears to apply. As everyday tasks of the oral cavity such as physical trauma from chewing 
food, tooth brushing, scaling, root surface debridement, extractions and periodontal surgery 
(Carroll and Sebor, 1980; Lofthus et al., 1991; Daly et al., 1997; 2001; Kinane et al., 2005; 
Savarrio et al., 2005; Forner et al., 2006; Tomas et al., 2007) all contribute to transient 
bacteraemia.  
Previously the brain was considered as an immune-privileged microenvironment due 
to the existence of a BBB, which denied access of systemic proteins and immune cells into 
the CNS (Oldfield and Mckinley, 1995). However, it is now recognised that the BBB is 
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incomplete in the circumventricular organs and the choroid plexus regions (Oldfield and 
Mickinley, 1995) providing an opportunity for systemic proteins and cells to gain access at 
these sites of the CNS. Microglial cells in circumventricular organs express CD14 receptor 
and the TLR-4 and are therefore, capable of detecting the non-self, pathogen associated 
molecular patterns on bacteria and LPS (Oldfield and Mickinley, 1995; Lacroix et al., 1998; 
Beutler et al., 2003). 
All of the above factors facilitate the inflammatory stimuli to reach the brain and 
contribute to the activation of astrocytes and microglial cells. The in vitro study design 
described in this thesis was preferred over an in vivo animal model approach as experimental 
conditions and analysis could be performed on large cell numbers of a homogenous astrocyte 
and neuronal cell populations.  
Although, this study intended to test responses of periodontal pathogens directly 
exposed to cells of interest, logistical reasons and time restraints made this impossible. To 
understand how a pathogen such as P. gingivalis may incite the innate immune system upon 
access to the CNS, this project investigated the acute phase responses of cells following 
treatment with a cocktail of virulence factors in the form of spent medium. The rationale for 
using a cocktail of virulence factors together rather than selected ones on their own was that 
the whole organisms reside in the body and their crude endotoxin mixtures are likely to 
contribute to the cumulative pathogenic effect during life. Biochemical methodologies to 
either synthesize or isolate individual virulence factors to purity are unable to exert their 
biological effect on cells to the same extent as the additive effect of the crude endotoxin 
mixtures released by the organism. 
The spent medium contained endotoxins including LPS and the outer membrane 
vesicles, gingipains, propionic and butyric acids, to mention a few from gram-negative 
anaerobic P. gingivalis periodontal pathogen. 
 
3.1. Exposure of cells to P. gingivalis virulence factors affect cellular immune responses 
 
Membrane blebbing 
Following treatment of cells with the aforementioned virulence factors they initiated a 
spectrum of cellular responses. Due to the increased resistance to bacterial infections 
(antibiotic free culture conditions), the SVGp12 glial cell line, provided the most dramatic 
responses to LPS and gingipains. These included perturbation of the surface membrane in the 
form of “blebbing” observed following immunolabelling using the anti-P. gingivalis (clone 
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1B5) antibody. The combined microscopy based immunolabelling and biochemistry based 
immunoblotting data demonstrated this was likely to be due to the LPS binding to the cell 
membrane as gingipains (anti-gingipains clone 1A1) localised mainly to peri-nuclear sites in 
the cytoplasm and within lysosomes of the SVGp12 glial cells. Blebbing of the non-CNS 
cells has also been reported to take place due to reasons other than bacterial endotoxins 
including exposure of cells to serum, macroglobulin 2 (Dixon et al., 1987) and hyperthermia 
(Borrelli et al., 1986) and apoptotic cell death (Zierler et al., 2006). LPS is commonly 
considered as an important virulence factor in gram-negative bacteria. Although not 
conclusive, our results indicate, the CNS cells are particularly sensitive to LPS. 
Loss of cell adhesion  
Morphological changes, of which the dominant feature was cell detachment suggests the 
adhesion of the cells was disturbed. Although not conclusively tested, and it is our view that 
LPS alone is unlikely to disturb the adhesion of cells. It is reported that the metabolic by 
products of the pathogens may contribute to disruption of adhesion of cells to their substrates 
(Scragg et al., 1994). Alternatively, LPS may initiate signalling pathways that lead to other 
proteases being activated that disturb adhesion of cells. 
From the cocktail of endotoxins, it is likely that gingipains is also contributing to 
detachment of cells (Fujimura and Nakamura, 1987). Gingipains is a protease enzyme which 
displays commonalities between the activities of trypsin, to degrade matrix proteins 
(Nakamura et al., 1991) such as fibronectin and collagen. These matrix proteins provide a 
source of receptors that allow anchorage of cells in vitro and link cytoskeletal proteins to 
regulate cell migration and cell adhesion. If these contacts are disrupted in vitro the cells 
become detached.  
Trypsin is used in cell culture methodologies to detach adherent cells for sub-
culturing purposes and it is likely that gingipains can also mediate the rounding of cells and 
detach them from the plastic/glass substrate in a similar way. In support, trypsin hydrolyses 
lysine-arginine and lysine-arginine-proline bonds to detach adherent cells in culture. Two 
different forms of gingipains are known to be secreted by the same organism in culture. Both 
types are known to hydrolyse either lysine or arginine residues on cell membranes (Pike et 
al., 1994). The reasons for hydrolysis of proteins native to the host by gingipains may be to 
generate peptides from the host for growth of P. gingivalis. Whether cell detachment is 
cytopathic is not known but, this investigation found that the detached cells recovered the 
ability to re-attach to the plastic and grow once they were free of the virulence factors.  
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Anti-proliferative response 
The virulence factors also appeared to growth arrest cells especially those having lost their 
adhesion. It is possible that the inhibitory effect of proliferation is partly due to LPS as Hill 
and Ebersole (1996) found in their study whereby LPS from Actinobacillus 
actinomycetemcomitans was applied at high concentrations resulting in the reduction of DNA 
synthesis in quiescent fibroblasts. Layman and Diedrich (1987) also reported that purified 
LPS from P. gingivalis could inhibit gingival fibroblast cell proliferation by 50%. 
Furthermore, crude preparations of LPS from P. gingivalis have similar effect on gingival 
fibroblasts as that caused by native extract of the whole bacteria (Larjava et al., 1987) 
indicating the growth inhibition observed in this project was likely to be mediated by the LPS 
or by gingipains detaching cells. 
CD14 mediated LPS- signalling pathway  
The SVGp12 cells were very responsive to P. gingivalis LPS and other virulence factors 
present in the spent medium. This study demonstrates that SGVp12 cells challenged with the 
virulence factors reduced cell surface membrane bound CD14 receptor protein. Gingipains is 
reported to cleave CD14 from macrophage like cells by direct proteolytic activity resulting in 
its shedding (Sugawara et al., 2000; Duncan et al., 2004). This mechanism is suggested as an 
immune evasion strategy employed by P. gingivalis bacteria for survival in host tissues (Tada 
et al., 2002). In addition, CD14 is a substrate for gingipains and can degrade it completely, 
suggesting that gingipains efficiently digest CD14 to small fragments that are not detected by 
immunoblotting using anti-CD14 antibody (Sugawara et al., 1998; Tada et al., 2002).  
The neuroblastoma cell line IMR32 cells in particular showed complete absence of 
the CD14 protein following challenge with P. gingivalis spent medium despite the abundance 
of this receptor on these cells. Two main reasons for its complete absence is that either the 
receptor was shed once the cells were in contact with the LPS from the spent medium or it 
was down regulated at the gene level by IL-13 cytokine as is reported to occur in human 
monocytes (Cosentino et al., 1995) or completely degraded by gingipains beyond detection 
by immunoblotting (Sugawara et al., 2000; Tada et al., 2002). LPS from gram-negative 
bacteria binds to CD14 which complexes with TLR-4. Although TLRs can bind the 
endotoxins directly, CD14 is essential to increase the sensitivity of the response to endotoxins 
by as much as 1000-fold. Briefly the sequence of events in the recognition of LPS by cells 
may involve a binding protein. The role of the binding protein is to separate LPS into single 
molecules and transfer them to CD14. The CD14-LPS complex is then presented to TLR4 
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and its adaptor protein MD-2 via MyD88 or not, initiating intracellular signally cascades as 
shown in figure 3.1. 
 
 
Figure 3.1: Schematic diagram representing interaction of LPS to CD14 signalling pathways. Schematic 
diagram showing the interaction of LPS to the CD14 located in the cell surface membrane initiating signalling 
pathways by complexing with MD-2 (an adapter protein) independent of MyD88. 
 
The pathways involved are the MyD88 dependent signalling pathway, common to all the 
TLRs, and the MyD88-independent signalling pathway, is specific to TLR-3 and TLR-4. The 
MyD88-dependent signalling cascade leads to the activation of NF-κB (Figure 3.1). 
Activation of NF-κB allows it to enter the nucleus and induce the expression of multiple 
target genes, such as TNF-α, IL-1, IL-6, IL-8, and others. In addition, the MyD88-dependent 
signalling pathway leads to the activation of mitogen-activated protein kinases (MAPK), 
which leads to the production of nitric oxide and additional inflammatory mediators. 
Inflammatory cytokine release 
A number of reports suggest astrocytes have the capacity to synthesise and secrete cytokines 
by exposure to proinflammatory stimuli (Aloisi et al., 1992; Choi et al., 2002; Lu et al., 2005; 
Spooren et al., 2011; Burkert et al., 2012). As a result of LPS interaction with CD14 and the 
TLR-4, production of proinflammatory cytokines (IL-1β, IL-6, IL-8, TNF-α) by human 
astrocyte SVGp12 cell line was expected. This study revealed that following exposure to P. 
gingivalis (W50) virulence factors, the SVGp12 glial cells up-regulated the secretion mainly 
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of the chemokine IL-8 (from pico to nanoMoles/ml) whereas IL-6 and TNF-α remained at 
their physiological concentrations (picomoles/ml). IL-8 is a chemokine that mediates acute 
phase inflammatory activity and its induction is likely to be due to LPS which has been 
shown in vitro in human umbilical vein endothelial cells (Mao et al., 2002) and in vivo 
(rodents) following administration of bacterial LPS (Feghali and Wright, 1997). IL-8 
mediates the recruitment and activation of neutrophils in inflamed tissues (Huber et al., 
1991). In the same way, it is proposed here that IL-8 production by astrocytes would result in 
the activation and recruitment of microglia to the site of infection/injury in the brain.  
The suppression of pro-inflammatory cytokines especially IL-6 and TNF- could be 
explained by the pathogenicity of the periodontal pathogens used. LPS from P. gingivalis 
(33277 and W50) inhibited the production of the pro-inflammatory mediators tested at 24h 
time point. Although IL-1was not analysed, literature suggests that its secretion following 
challenge with LPS from encapsulated P. gingivalis W50 is up-regulated in whole blood 
(Kunnen et al., 2012). Secretion of IL-1 and TNF- can mediate the up-regulation of IL-6 
(Aloise et al., 1992; Spooren et al., 2011). Both IL-6 and TNF- release were also 
suppressed suggesting IL-1 may not have been up-regulated by the P. gingivalis virulence 
factors applied to SVGp12 cells. Alternatively, these results may be genuine as in another 
investigation, LPS failed to stimulate mRNA or protein expression for IL-1β, TNF-α and IL-
6 in pure astrocyte cultures (Lee et al., 1993). One reason may be that astrocytes do not 
express TLR-4 (Lehnardt et al., 2002) which is necessary to complex with the CD14 receptor 
to respond to LPS for switching on intracellular signalling.  
This study did not investigate if SGVp12 cells expressed TLR-4. However, IL-8 was 
induced and that indicated some form of intracellular signalling mediated by NF-kB 
transcription factor was taking place. A study performed following Burkholderia 
pseudomallei infection in human embryonic kidney cells suggests that IL-8 secretion can 
occur without TLR-4 and this takes place via the NF-kB and a family of stress activated 
serine/threonine protein kinases such as mitogen-activated protein kinase 38 (p38 MAPK) 
and the c-jun N-terminal kinase (JNK) pathways (Hill et al., 2008). TLR-independent 
activation depends on a functional Bsa type III secretion system and requires internalization 
of the bacterium (Hill et al., 2008). Alternatively, gingipains also induces the synthesis of IL-
8 in the human artery endothelial cells involving the TLR signalling and is its synthesis is 
enhanced in the presence of LPS and gingipains (Deng et al., 2011).  
Another report suggests that P. gingivalis LPS challenged primary rodent astrocytes 
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release nitric oxide and prostaglandin E2 (Shapira et al., (2002). This suggests another path 
of inflammatory mediator release by astrocytes in conjunction with LPS involving the L-
arginine-nitric oxide pathway. The activation of this pathway is enhanced in the presence of 
IL-1 and TNF- cytokines (Mollace et al., 1998). This study did not attempt to reproduce 
the Shapira et al., (2002) data as two different ELISA assays revealed TNF- was not 
induced above its physiological levels by SVGp12 astrocytes. However, nitric oxide and 
prostaglandin E2 have a knock on effect on the induction of IL-1 and TNF- cytokines due 
to the activation of the cyclooxygenase enzymes by nitric oxide (Mollace et al., 1998; 
Salvemini et al., 1993). Astrocytes become activated in response to cytokines and may play a 
neuro-protective role from nitric oxide toxicity (Chen et al., 2001) to induce and stabilize 
neuronal synapses (Christopherson et al., 2005; Ullian et al., 2001).  
LPS mediated signal transduction pathways switch on the p38 MAPK (Obata et al., 
2000) and the JNK (Obata et al., 2000; Scheinfeld et al., 2002) can mediate neuronal loss by 
apoptosis (Nakahara et al., 1998) and are activated in neurodegenerative diseases such as AD 
(Hensley et al., 1999; Zhu et al., 2004). The neuroblastoma cell line IMR32 was unable to 
release any of the cytokines tested and this data is in agreement with Lu et al., (2005). It is 
plausible to suggest that these cells may acquire protection from glial cell synthesised 
immune effectors or become targets of damage during chronic inflammatory environment. 
Elevated levels of cytokines have been reported in the AD brains (Akiyama et al. 2000) as 
well as the serum of AD patients during life (Holmes et al., 2009). Periodontal pathogens are 
also implicated in contributing to the pool of these cytokines in AD patients (Kamer et al., 
2009). The paracrine effect of cytokines may contribute to glial cell priming following long 
term stimulation of trigeminal peripheral nerve fibres which connect to the brain. Several 
bacteria, including periodontal pathogens, have been found in the aged and the AD brain 
specimens (Riviere et al., 2002) including our own in house data. Riviere et al., (2002) 
studies have demonstrated that spirochete species can migrate to the brain via the trigeminal 
nerve ganglia.  
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3.2. Repeat-exposure of cells to P. gingivalis virulence factors contributed to higher IL-8 
chemokine release  
 
Studies in animal models representing the aged brain suggest that a short exposure (4h 
exposure) to as much as 0.33 mg of bacterial LPS in the systemic circulation is required to 
illicit an overwhelming inflammatory response (Ye and Johnson, 1999; 2001; Godbout et al., 
2005; Chen et al., 2008) which can alter BBB permeability and change resting microglia into 
their activated phenotype (Ye and Johnson, 1999; 2001; Chen et al., 2008). These studies (Ye 
and Johnson, 1999; 2001; Godbout et al., 2005; Sheng et al., 2003; Chen et al., 2008) imply 
that the direct transport of the LPS to brain via antigen presenting cells may not be taking 
place but instead the brain may be directly exposed to secondary mediators (cytokines). This 
introduces a new hypothesis that if microglia in the aged brain are in an inflammatory 
immune-phenotype further stimulations from circulating inflammatory mediators due to 
severe periodontitis, will cause them to respond by expressing copious amounts of 
inflammatory cytokines that exacerbate pre-existing neurodegeneration. 
 This investigation tested the concept by repeat infections of the recovered cells using 
IL-8 secretion as a guide. Following treatments of SVGp12 cells with the P. gingivalis 33277 
spent medium, IL-8 levels failed to increase over and above the level observed in controls. 
However this was only measured once as the assay was expensive. Further studies are 
necessary to conclude this finding but with P. gingivalis W50 spent medium.  
 
3.3.   Exposure of cells to P. gingivalis virulence factors affects the actin cytoskeleton 
but, without cell death 
 
Following binding of LPS to SVGp12 cells, the anti-P. gingivalis (clone 1B5) antibody 
demonstrated, marked alteration in cell morphology, reduced cell attachment (rounded cells) 
and altered F-actin stress in treated cells. All cells including the SVGp12 glial and the IMR32 
neuroblastoma cell lines demonstrated these cells have a structural framework of actin which 
can be dynamically remodelled in response to internal or external signals. Actin protein is 
central to neurons which have dendrites and an axon that extends over long distances. Several 
molecules are thought to transmit signals from the plasma membrane to the actin 
cytoskeleton ranging from small GTPases to phosphoinositol (Majerus et al., 1990). Binding 
of specific receptors initiates a cascade of events that activates the machinery involved in 
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movement resulting in the remodelling of the actin cytoskeleton (Sechi and Wehland, 2000). 
Damage caused by periodontal virulence factors is detrimental to the proper function of these 
important cells. Microglial cells are not only phagocytic cells but also immune surveyors of 
the brain. Actin protein facilitates phagocytic activity by extending protoplasmic protrusions 
of the cell (Carnell and Insall, 2011) to internalise foreign/cellular debris and cellular 
movement is essential to combat immune responses to a variety of extracellular stimuli 
(pathogens and their virulence factors) and LPS may play a detrimental role. 
In conclusion this investigation has highlighted some important responses of CNS 
cells caused by P. gingivalis virulence factors. Research assessing potential relationships 
between periodontal pathogens and their impact on early pathological signs contributing to 
cognitive dysfunction is important for uncovering unique mechanisms that lead to the 
development of dementia. The long term significance of this research lies in the potential to 
confirm these results in animal models of periodontal disease and develop interventional 
clinical trials which may reduce the severity of periodontal diseases in, at risk individuals, 
implementing relatively cost-effective professional oral hygiene regimes.  
 
Suggestions for future work 
 
This study has highlighted that the various cell surface and cytoskeletal proteins synthesis 
becomes completely disturbed on the neuroblastoma cell line IMR32 cells and the SGVp12 
astrocytes following a challenge with the P. ginivalis 33277 and W50 endotoxins.  Changes 
in the CD14 protein on IMR32 cells were interesting and future studies should explore if the 
CD14 receptor on IMR32 cells was being shed during exposure to the endotoxins or whether 
the protein was down regulated at the gene level. These tests can be performed using western 
blotting of the supernatants collected following treatment and real time polymerase chain 
reaction on total RNA isolated from cells. The effect of a mixture of virulence factors from 
the red complex periodontal pathogens (P. gingivalis, T. forsythia and T. denticola) on CNS 
cells would be interesting if and when suitable antibodies become available. 
To strengthen the relevance of this in vitro finding that CD14 receptor protein levels 
change should be followed in an animal model induced with periodontal disease by the same 
organism. Our research group has access to the ApoE
null
 mice orally infected (N=12) with 10
9
 
P. gingivalis via an established collaboration with Professor L. Kesavalu (University of 
Florida).  
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The Bioplex cytokine assay should be repeated to conclude the described findings as it was 
only measured once due to high cost of the assay. Further studies are necessary on using a 
mixed set of virulence factors from the red complex organisms to find out if there is a 
synergistic effect on cells and especially on microglial cell lines as they are the main cells 
that respond to immune challenges in the brain.  
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